Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Medtronic plc (MDT)
USD83.57
-0.30 (-0.36%)
US NYSE S&P 500
Healthcare Medical - Devices
Address
Building Two, Parkmore Business Park West 2
Galway, US
Galway, US
CEO
Geoffrey Straub Martha
Website
medtronic.com
IPO
1973-05-02
CIK 1613103 ISIN IE00BTN1Y115
Also trades on
Deutsche Börse · 2M6.DE (EUR)
London Stock Exchange · 0Y6X.L (USD)
New York Stock Exchange · MDT (USD)
Description
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
News Sentiment (7d)
3 articles
- Medtronic: Guidance Built To Be Beaten - Buy Seeking Alpha
- Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Date | Filing |
|---|---|---|
| IRSUB | 2015-07-17 | View |
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 1986-10-23 | — | Active |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD83.57
-0.30 (-0.36%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
10M
Beta
0.60
Float Shares
1.28B
Free Float %
99.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +5.69% | +2.77% | -2.56% | -19.40% | -23.56% | -18.85% | -8.87% | -6.90% | -36.66% | -6.02% | +24,766.02% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (49 ratings, all time)
Buy
Price Targets & DCF
Current price
83.57
Low
80.00
-4.3%
Consensus
101.29
+21.2%
Median
100.50
+20.3%
High
119.00
+42.4%
DCF (Unlevered)
202.12
+141.9%
DCF (Levered)
169.28
+102.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
59% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 15 | +1 |
| Hold | 13 | +1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
84.00
+0.5%
|
| Last Quarter | 7 |
105.57
+26.3%
|
| Last Year | 25 |
108.96
+30.4%
|
| All Time | 85 |
107.40
+28.5%
|
Quality scores
Altman Z-Score
2.75
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+8.4% Q2'26: +9.9% (vs Q2'25)
-
EPS growth Medical - Devices: +28.5%+3.3% Q2'26: +17.1% (vs Q2'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+12.3% Q2'26: +23.5% (vs Q2'25)
-
EBIT margin Medical - Devices: +6.2%+0.0% Q2'26: +0.0% (vs Q2'25)
-
ROIC Medical - Devices: +3.3%— Q2'26: +0.0% (vs Q2'25)
-
Share dilution Medical - Devices: 0.0%-0.1% ★ Q2'26: +0.0% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×— Q2'26: 3.75× (vs Q2'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Apr 1998 actual |
Apr 1999 actual |
Apr 2000 actual |
Apr 2001 actual |
Apr 2002 actual |
Apr 2003 actual |
Apr 2004 actual |
Apr 2005 actual |
Apr 2006 actual |
Apr 2007 actual |
Apr 2008 actual |
Apr 2009 actual |
Apr 2010 actual |
Apr 2011 actual |
Apr 2012 actual |
Apr 2013 actual |
Apr 2014 actual |
Apr 2015 actual |
Apr 2016 actual |
Apr 2017 actual |
Apr 2018 actual |
Apr 2019 actual |
Apr 2020 actual |
Apr 2021 actual |
Apr 2022 actual |
Apr 2023 actual |
Apr 2024 actual |
Apr 2025 actual |
Apr 2026 14 Rev. Ana. 14 EPS Ana. |
Apr 2027 22 Rev. Ana. 17 EPS Ana. |
Apr 2028 23 Rev. Ana. 9 EPS Ana. |
Apr 2029 5 Rev. Ana. 2 EPS Ana. |
Apr 2030 4 Rev. Ana. 1 EPS Ana. |
Apr 2031 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.60B
est: 2.44B (+6.7%)
|
4.13B
est: 2.74B (+51.0%)
|
5.01B
est: 4.42B (+13.4%)
|
5.55B
est: 5.36B (+3.5%)
|
6.41B
est: 5.85B (+9.5%)
|
7.67B
est: 6.99B (+9.7%)
|
9.09B
est: 8.29B (+9.6%)
|
10.05B
est: 9.54B (+5.4%)
|
11.29B
est: 10.71B (+5.4%)
|
12.30B
est: 11.59B (+6.1%)
|
13.52B
est: 12.10B (+11.7%)
|
14.60B
est: 14.20B (+2.8%)
|
15.82B
est: 14.84B (+6.6%)
|
15.93B
est: 15.53B (+2.6%)
|
16.18B
est: 16.34B (-0.9%)
|
16.59B
est: 16.27B (+1.9%)
|
17.01B
est: 16.33B (+4.2%)
|
20.26B
est: 28.24B (-28.3%)
|
28.83B
est: 28.73B (+0.4%)
|
29.71B
est: 29.68B (+0.1%)
|
29.95B
est: 29.70B (+0.9%)
|
30.56B
est: 30.52B (+0.1%)
|
28.91B
est: 29.68B (-2.6%)
|
30.12B
est: 30.06B (+0.2%)
|
31.69B
est: 32.02B (-1.0%)
|
31.23B
est: 30.94B (+0.9%)
|
32.36B
est: 33.00B (-1.9%)
|
33.54B
est: 33.51B (+0.1%)
|
36.15B
36.13B – 36.18B
+7.9% YoY
|
38.24B
37.36B – 38.84B
+5.8% YoY
|
39.67B
39.62B – 39.72B
+3.7% YoY
|
41.49B
41.24B – 41.75B
+4.6% YoY
|
43.71B
41.89B – 44.71B
+5.3% YoY
|
46.80B
44.85B – 47.87B
+7.1% YoY
|
| EBITDA |
1.26B
est: 938.87M (+34.0%)
|
1.58B
est: 858.95M (+83.9%)
|
1.93B
est: 1.28B (+50.3%)
|
2.18B
est: 2.01B (+8.4%)
|
2.48B
est: 1.59B (+55.9%)
|
3.06B
est: 2.30B (+33.0%)
|
3.62B
est: 3.06B (+18.6%)
|
3.91B
est: 3.40B (+14.9%)
|
4.25B
est: 2.80B (+52.0%)
|
4.32B
est: 4.11B (+5.2%)
|
3.78B
est: 3.96B (-4.6%)
|
3.51B
est: 3.37B (+4.1%)
|
5.12B
est: 3.48B (+46.9%)
|
4.92B
est: 5.25B (-6.3%)
|
5.33B
est: 5.20B (+2.4%)
|
5.46B
est: 5.37B (+1.7%)
|
4.93B
est: 5.66B (-12.9%)
|
5.46B
est: 4.76B (+14.6%)
|
8.54B
est: 6.59B (+29.6%)
|
8.61B
est: 8.62B (-0.1%)
|
9.47B
est: 8.83B (+7.1%)
|
9.30B
est: 6.15B (+51.1%)
|
7.81B
est: 8.93B (-12.5%)
|
7.52B
est: 6.58B (+14.3%)
|
8.78B
est: 7.81B (+12.4%)
|
8.70B
est: 9.01B (-3.5%)
|
8.20B
est: 9.50B (-13.6%)
|
9.22B
est: 9.64B (-4.4%)
|
10.40B
10.40B – 10.41B
+7.9% YoY
|
11.01B
10.75B – 11.18B
+5.8% YoY
|
11.42B
11.40B – 11.43B
+3.7% YoY
|
11.94B
11.87B – 12.02B
+4.6% YoY
|
12.58B
12.06B – 12.87B
+5.3% YoY
|
13.47B
12.91B – 13.78B
+7.1% YoY
|
| EBIT |
1.09B
est: 813.84M (+34.1%)
|
1.36B
est: 908.24M (+49.8%)
|
1.68B
est: 1.39B (+21.2%)
|
1.88B
est: 1.76B (+6.8%)
|
2.15B
est: 1.97B (+9.1%)
|
2.65B
est: 2.37B (+12.2%)
|
3.18B
est: 2.82B (+12.8%)
|
3.44B
est: 3.30B (+4.2%)
|
3.71B
est: 3.60B (+2.9%)
|
3.74B
est: 3.66B (+2.1%)
|
3.14B
est: 3.65B (-13.9%)
|
2.81B
est: 4.47B (-37.1%)
|
4.35B
est: 4.09B (+6.2%)
|
4.11B
est: 4.33B (-4.9%)
|
4.49B
est: 4.98B (-9.8%)
|
4.64B
est: 5.05B (-8.1%)
|
4.08B
est: 4.71B (-13.3%)
|
4.15B
est: 4.83B (-14.0%)
|
5.72B
est: 3.90B (+46.6%)
|
5.70B
est: 5.36B (+6.2%)
|
6.82B
est: 5.81B (+17.5%)
|
6.64B
est: 5.94B (+11.8%)
|
5.15B
est: 6.04B (-14.7%)
|
4.82B
est: 3.48B (+38.5%)
|
6.07B
est: 4.96B (+22.3%)
|
6.00B
est: 5.92B (+1.3%)
|
5.56B
est: 6.88B (-19.2%)
|
6.36B
est: 6.99B (-9.0%)
|
7.54B
7.53B – 7.54B
+7.9% YoY
|
7.97B
7.79B – 8.10B
+5.8% YoY
|
8.27B
8.26B – 8.28B
+3.7% YoY
|
8.65B
8.60B – 8.70B
+4.6% YoY
|
9.11B
8.73B – 9.32B
+5.3% YoY
|
9.76B
9.35B – 9.98B
+7.1% YoY
|
| Net Income |
594.60M
est: 544.73M (+9.2%)
|
468.40M
est: 463.26M (+1.1%)
|
1.10B
est: 629.40M (+74.5%)
|
1.05B
est: 1.19B (-12.0%)
|
984.00M
est: 809.83M (+21.5%)
|
1.60B
est: 1.30B (+23.0%)
|
1.96B
est: 1.84B (+6.4%)
|
1.80B
est: 2.09B (-13.5%)
|
2.55B
est: 1.87B (+36.3%)
|
2.80B
est: 2.64B (+6.1%)
|
2.23B
est: 2.75B (-18.9%)
|
2.17B
est: 2.15B (+0.9%)
|
3.10B
est: 2.11B (+46.7%)
|
3.10B
est: 3.14B (-1.4%)
|
3.62B
est: 3.37B (+7.5%)
|
3.47B
est: 3.43B (+1.2%)
|
3.07B
est: 3.71B (-17.5%)
|
2.68B
est: 2.90B (-7.7%)
|
3.54B
est: 2.25B (+57.1%)
|
4.03B
est: 4.20B (-4.2%)
|
3.10B
est: 4.77B (-34.9%)
|
4.63B
est: 2.10B (+120.2%)
|
4.79B
est: 4.47B (+7.1%)
|
3.61B
est: 3.56B (+1.2%)
|
5.04B
est: 4.39B (+14.8%)
|
3.76B
est: 3.62B (+3.8%)
|
3.68B
est: 4.29B (-14.3%)
|
4.66B
est: 7.04B (-33.7%)
|
7.15B
7.07B – 7.24B
+1.7% YoY
|
7.81B
7.61B – 8.01B
+9.2% YoY
|
8.37B
7.53B – 9.22B
+7.2% YoY
|
9.13B
8.92B – 9.33B
+9.0% YoY
|
9.90B
9.36B – 10.19B
+8.4% YoY
|
10.32B
9.76B – 10.62B
+4.3% YoY
|
| SGA |
1.05B
est: 748.27M (+40.6%)
|
1.33B
est: 775.50M (+70.9%)
|
1.58B
est: 1.41B (+11.9%)
|
1.69B
est: 1.66B (+1.6%)
|
1.96B
est: 1.77B (+10.9%)
|
2.37B
est: 2.17B (+9.1%)
|
2.80B
est: 2.63B (+6.6%)
|
3.21B
est: 3.01B (+6.8%)
|
3.66B
est: 3.44B (+6.4%)
|
4.15B
est: 3.82B (+8.7%)
|
4.71B
est: 4.13B (+13.8%)
|
5.87B
est: 4.97B (+18.0%)
|
5.28B
est: 5.11B (+3.5%)
|
5.43B
est: 5.71B (-5.0%)
|
5.62B
est: 5.22B (+7.8%)
|
5.70B
est: 5.64B (+1.0%)
|
5.85B
est: 5.58B (+4.7%)
|
6.90B
est: 5.99B (+15.3%)
|
9.47B
est: 8.42B (+12.5%)
|
10.02B
est: 9.43B (+6.2%)
|
10.24B
est: 9.41B (+8.7%)
|
10.42B
est: 9.90B (+5.2%)
|
10.11B
est: 9.92B (+1.9%)
|
10.15B
est: 10.21B (-0.6%)
|
10.29B
est: 9.60B (+7.2%)
|
10.42B
est: 10.60B (-1.7%)
|
10.74B
est: 10.89B (-1.4%)
|
10.85B
est: 11.06B (-1.9%)
|
11.93B
11.93B – 11.94B
+7.9% YoY
|
12.62B
12.33B – 12.82B
+5.8% YoY
|
13.09B
13.08B – 13.11B
+3.7% YoY
|
13.70B
13.61B – 13.78B
+4.6% YoY
|
14.43B
13.83B – 14.76B
+5.3% YoY
|
15.45B
14.81B – 15.80B
+7.1% YoY
|
| EPS |
0.52
est: 0.58 (-10.3%)
|
0.40
est: 0.67 (-40.3%)
|
0.91
est: 0.82 (+11.0%)
|
0.87
est: 1.00 (-13.0%)
|
0.81
est: 1.11 (-27.0%)
|
1.31
est: 1.30 (+0.8%)
|
1.61
est: 1.51 (+6.6%)
|
1.49
est: 1.73 (-13.9%)
|
2.11
est: 2.01 (+5.0%)
|
2.44
est: 2.23 (+9.4%)
|
1.97
est: 2.29 (-14.0%)
|
1.85
est: 2.68 (-31.0%)
|
2.80
est: 2.99 (-6.4%)
|
2.87
est: 3.21 (-10.6%)
|
3.43
est: 3.35 (+2.4%)
|
3.40
est: 3.54 (-4.0%)
|
3.06
est: 3.62 (-15.5%)
|
2.44
est: 4.32 (-43.5%)
|
2.51
est: 4.37 (-42.5%)
|
2.92
est: 4.58 (-36.2%)
|
2.29
est: 4.73 (-51.6%)
|
3.44
est: 5.15 (-33.2%)
|
3.57
est: 4.98 (-28.3%)
|
2.68
est: 4.36 (-38.5%)
|
3.75
est: 5.66 (-33.7%)
|
2.83
est: 5.27 (-46.3%)
|
2.77
est: 3.28 (-15.6%)
|
3.63
est: 5.46 (-33.5%)
|
5.52
5.49 – 5.62
+1.1% YoY
|
6.05
5.91 – 6.22
+9.6% YoY
|
6.48
5.85 – 7.16
+7.1% YoY
|
7.09
6.93 – 7.24
+9.4% YoY
|
7.68
7.27 – 7.91
+8.4% YoY
|
8.01
7.58 – 8.25
+4.3% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-22 | UBS | Neutral | Neutral | Maintain |
| 2026-04-15 | Truist Securities | Hold | Hold | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-01 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
5.81B
OE per share TTM
4.52
Owner's Yield
6.14%
Maintenance CapEx ratio
27.60%
Maint CapEx / Avg PPE
17.7%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
2,273
Total invested
95.55B
Insider transactions (90d)
28
Beneficial owners (>5%)
14
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group - 23-1945930 | 113.15M | 8.42% | — | 2.13M | 107.73M | 5.43M | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 2 | Wellington Management Company LLP | 68.29M | 5.05% | — | 20.26M | — | — | IA | Massachusetts | 2018-02-08 | ↗ |
| 3 | Wellington Group Holdings LLP | 38.65M | 2.87% | — | 38.10M | — | — | HC | Massachusetts | 2021-02-03 | ↗ |
| 4 | Wellington Investment Advisors Holdings LLP | 38.65M | 2.87% | — | 38.10M | — | — | HC | Massachusetts | 2021-02-03 | ↗ |
| 5 | Wellington Management Group LLP | 38.65M | 2.87% | — | 38.10M | — | — | HC | Massachusetts | 2021-02-03 | ↗ |
| 6 | T. ROWE PRICE ASSOCIATES, INC. | 7.19M | 8.60% | 2.61M | 142.0K | 86.97M | 2.77M | IA | Pennsylvania | 2016-02-10 | ↗ |
| 7 | Covidien Group S.a.r.l. | 5.00M | 15.80% | — | 5.00M | — | 5.00M | OO | Ireland | 2023-02-06 | ↗ |
| 8 | Medtronic plc | 5.00M | 15.80% | — | 5.00M | — | 5.00M | OO | Ireland | 2023-02-06 | ↗ |
| 9 | Page 2 of 7 Pages | 4.21M | 16.00% | — | 4.21M | — | 4.21M | OO | Ireland | 2017-09-15 | ↗ |
| 10 | Page 3 of 7 Pages | 4.21M | 16.00% | 4.21M | — | 4.21M | — | OO | Ireland | 2017-09-15 | ↗ |
| 11 | 8.2% (2) | 782.3K | 8.20% | 782.3K | — | 782.3K | — | CO | Ireland | 2016-02-16 | ↗ |
| 12 | (10) | 460.3K | 1.60% | 460.3K | — | 460.3K | — | OO | Ireland | 2016-02-16 | ↗ |
| 13 | Alpa Capital Anstalt | 445.1K | 4.70% | 70.60M | 17.9K | 82.25M | 17.9K | CO | Delaware | 2016-02-09 | ↗ |
| 14 | Medtronic, Inc. | — | 0.00% | — | — | — | — | CO | Ireland | 2019-02-01 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
2,273
-94 vs prev Q
New positions
183
Closed positions
269
Increased
1,086
Reduced
877
Put/Call ratio
0.59
Calls held
6.81M
Puts held
4.02M
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 128.96M +1.9M (+1.5%) | 12.39B +285.6M (+2.4%) | 10.06% +0.143 pp | 0.18% -0.002 pp | USD82.85 +15.9% | 44 qtrs — |
| 2 | BLACKROCK, INC. | 120.54M +969.1K (+0.8%) | 11.58B +191.1M (+1.7%) | 9.40% +0.072 pp | 0.20% -0.004 pp | USD89.72 +7.1% | 6 qtrs — |
| 3 | STATE STREET CORP | 61.66M +1.2M (+2.0%) | 5.97B +166.2M (+2.9%) | 4.81% +0.092 pp | 0.20% -0.001 pp | USD83.22 +15.4% | 44 qtrs — |
| 4 | JPMORGAN CHASE & CO | 53.62M +1.4M (+2.7%) | 5.15B +179.3M (+3.6%) | 4.18% +0.110 pp | 0.32% +0.026 pp | USD92.04 +4.4% | 44 qtrs — |
| 5 | CAPITAL RESEARCH GLOBAL INVESTORS | 34.57M +3.9M (+12.6%) | 3.32B +397.9M (+13.6%) | 2.70% +0.302 pp | 0.61% +0.065 pp | USD96.22 -0.2% | 45 qtrs — |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 27.88M +231.9K (+0.8%) | 2.67B +45.4M (+1.7%) | 2.17% +0.017 pp | 0.16% -0.003 pp | USD88.77 +8.2% | 44 qtrs — |
| 7 | BANK OF AMERICA CORP /DE/ | 24.67M +424.6K (+1.8%) | 2.37B +60.7M (+2.6%) | 1.92% +0.032 pp | 0.17% +0.016 pp | USD90.32 +6.4% | 44 qtrs — |
| 8 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 20.95M -138.5K (-0.7%) | 2.01B +4.0M (+0.2%) | 1.63% -0.011 pp | 0.65% +0.027 pp | USD78.47 +22.4% | 44 qtrs — |
| 9 | MORGAN STANLEY | 20.22M -9.7K (0.0%) | 1.94B +15.7M (+0.8%) | 1.58% -0.001 pp | 0.12% -0.001 pp | USD89.60 +7.2% | 44 qtrs — |
| 10 | BANK OF NEW YORK MELLON CORP | 19.11M -2.4M (-11.0%) | 1.84B -208.8M (-10.2%) | 1.49% -0.184 pp | 0.33% -0.071 pp | USD93.28 +3.0% | 44 qtrs — |
| 11 | DEUTSCHE BANK AG\ | 17.75M +11.5K (+0.1%) | 1.70B +15.7M (+0.9%) | 1.38% +0.001 pp | 0.56% -0.011 pp | USD95.79 +0.3% | 44 qtrs — |
| 12 | NORGES BANK | 17.21M +17.2M (+100.0%) | 1.65B +1.7B (+100.0%) | 1.34% +1.343 pp | 0.18% +0.177 pp | USD96.06 +0.0% | 1 qtrs NEW |
| 13 | INVESCO LTD. | 16.23M +27.6K (+0.2%) | 1.56B +15.9M (+1.0%) | 1.27% +0.002 pp | 0.24% -0.004 pp | USD90.98 +5.6% | 44 qtrs — |
| 14 | ROYAL BANK OF CANADA | 13.99M -248.4K (-1.7%) | 1.34B -12.2M (-0.9%) | 1.09% -0.020 pp | 0.22% -0.004 pp | USD90.78 +5.8% | 44 qtrs — |
| 15 | WELLINGTON MANAGEMENT GROUP LLP | 13.36M +3.2M (+31.1%) | 1.28B +312.8M (+32.2%) | 1.04% +0.247 pp | 0.22% +0.055 pp | USD88.84 +8.1% | 44 qtrs — |
| 16 | FRANKLIN RESOURCES INC | 12.27M +775.2K (+6.7%) | 1.18B +83.9M (+7.7%) | 0.96% +0.060 pp | 0.29% +0.016 pp | USD87.08 +10.3% | 44 qtrs — |
| 17 | AMERIPRISE FINANCIAL INC | 12.00M -539.6K (-4.3%) | 1.15B -41.6M (-3.5%) | 0.94% -0.042 pp | 0.26% -0.014 pp | USD87.01 +10.4% | 44 qtrs — |
| 18 | NORTHERN TRUST CORP | 11.47M -658.0K (-5.4%) | 1.10B -53.3M (-4.6%) | 0.89% -0.052 pp | 0.14% -0.007 pp | USD79.29 +21.2% | 44 qtrs — |
| 19 | RAYMOND JAMES FINANCIAL INC | 11.25M +49.7K (+0.4%) | 1.08B +14.9M (+1.4%) | 0.88% +0.004 pp | 0.34% -0.006 pp | USD80.57 +19.2% | 5 qtrs — |
| 20 | LEGAL & GENERAL GROUP PLC | 10.18M +698.2K (+7.4%) | 978.07M +74.8M (+8.3%) | 0.79% +0.054 pp | 0.22% +0.014 pp | USD85.65 +12.2% | 37 qtrs — |
| 21 | FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 9.78M +40.2K (+0.4%) | 939.01M +11.8M (+1.3%) | 0.76% +0.003 pp | 1.65% -0.036 pp | USD81.41 +18.0% | 22 qtrs — |
| 22 | ALLIANCEBERNSTEIN L.P. | 9.20M +1.3M (+16.2%) | 884.21M +129.8M (+17.2%) | 0.72% +0.100 pp | 0.28% +0.042 pp | USD95.08 +1.0% | 44 qtrs — |
| 23 | UBS ASSET MANAGEMENT AMERICAS INC | 8.91M +279.2K (+3.2%) | 856.22M +33.9M (+4.1%) | 0.70% +0.022 pp | 0.18% +0.003 pp | USD88.43 +8.6% | 44 qtrs — |
| 24 | SCHRODER INVESTMENT MANAGEMENT GROUP | 8.47M +939.1K (+12.5%) | 813.53M +96.4M (+13.4%) | 0.66% +0.073 pp | 0.62% +0.063 pp | USD92.95 +3.3% | 44 qtrs — |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 8.31M +135.2K (+1.7%) | 798.35M +19.7M (+2.5%) | 0.65% +0.010 pp | 0.12% 0.000 pp | USD84.53 +13.6% | 44 qtrs — |
| 26 | DODGE & COX | 7.74M +13.0K (+0.2%) | 743.32M +7.6M (+1.0%) | 0.60% +0.001 pp | 0.40% +0.004 pp | USD80.89 +18.8% | 44 qtrs — |
| 27 | DIMENSIONAL FUND ADVISORS LP | 7.40M +23.3K (+0.3%) | 711.18M +8.4M (+1.2%) | 0.58% +0.002 pp | 0.15% -0.002 pp | USD81.13 +18.4% | 44 qtrs — |
| 28 | WELLS FARGO & COMPANY/MN | 7.04M +106.5K (+1.5%) | 676.20M +15.9M (+2.4%) | 0.55% +0.008 pp | 0.12% -0.002 pp | USD84.51 +13.7% | 44 qtrs — |
| 29 | CAPITAL WORLD INVESTORS | 7.04M +456.8K (+6.9%) | 675.86M +49.3M (+7.9%) | 0.55% +0.036 pp | 0.09% +0.006 pp | USD90.87 +5.7% | 4 qtrs — |
| 30 | ARISTOTLE CAPITAL MANAGEMENT, LLC | 6.93M -356.5K (-4.9%) | 665.67M -28.3M (-4.1%) | 0.54% -0.028 pp | 1.33% -0.008 pp | USD95.41 +0.7% | 44 qtrs — |
| 31 | BOSTON PARTNERS | 6.74M -230.1K (-3.3%) | 647.15M -17.3M (-2.6%) | 0.53% -0.018 pp | 0.67% -0.012 pp | USD88.99 +7.9% | 44 qtrs — |
| 32 | GOLDMAN SACHS GROUP INC | 5.87M -2.3M (-28.1%) | 563.94M -213.7M (-27.5%) | 0.46% -0.179 pp | 0.07% -0.026 pp | USD89.37 +7.5% | 44 qtrs — |
| 33 | STIFEL FINANCIAL CORP | 5.87M -243.0K (-4.0%) | 563.67M -18.3M (-3.1%) | 0.46% -0.019 pp | 0.51% -0.024 pp | USD93.18 +3.1% | 44 qtrs — |
| 34 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.78M -146.4K (-2.5%) | 554.97M -9.2M (-1.6%) | 0.45% -0.012 pp | 0.06% -0.001 pp | USD89.62 +7.2% | 44 qtrs — |
| 35 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 5.35M +91.0K (+1.7%) | 514.00M +13.1M (+2.6%) | 0.42% +0.007 pp | 0.42% +0.011 pp | USD84.83 +13.2% | 44 qtrs — |
| 36 | CITADEL ADVISORS LLC | 5.23M +1.5M (+41.3%) | 502.32M +149.8M (+42.5%) | 0.41% +0.119 pp | 0.08% +0.022 pp | USD90.98 +5.6% | 44 qtrs — |
| 37 | ENVESTNET ASSET MANAGEMENT INC | 5.17M -521.2K (-9.2%) | 496.98M -45.4M (-8.4%) | 0.40% -0.041 pp | 0.15% -0.009 pp | USD90.45 +6.2% | 43 qtrs — |
| 38 | AMERICAN CENTURY COMPANIES INC | 4.85M -949.3K (-16.4%) | 466.30M -86.4M (-15.6%) | 0.38% -0.074 pp | 0.23% -0.047 pp | USD90.84 +5.7% | 44 qtrs — |
| 39 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 4.82M -1.0M (-17.2%) | 463.08M -91.4M (-16.5%) | 0.38% -0.078 pp | 1.38% -0.330 pp | USD84.46 +13.7% | 44 qtrs — |
| 40 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 4.79M -311.6K (-6.1%) | 460.10M -25.8M (-5.3%) | 0.37% -0.024 pp | 0.26% -0.028 pp | USD88.00 +9.2% | 44 qtrs — |
| 41 | BEUTEL, GOODMAN & CO LTD. | 4.73M -33.5K (-0.7%) | 454.52M +690.0K (+0.2%) | 0.37% -0.003 pp | 2.79% +0.059 pp | USD80.19 +19.8% | 5 qtrs — |
| 42 | AMUNDI | 4.45M +441.5K (+11.0%) | 427.80M +32.9M (+8.3%) | 0.35% +0.034 pp | 0.12% -0.011 pp | USD101.48 -5.3% | 19 qtrs — |
| 43 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 4.24M +1.8M (+74.3%) | 406.93M +175.4M (+75.8%) | 0.33% +0.141 pp | 0.24% +0.092 pp | USD92.66 +3.7% | 24 qtrs — |
| 44 | BARROW HANLEY MEWHINNEY & STRAUSS LLC | 4.18M -223.4K (-5.1%) | 401.13M -17.9M (-4.3%) | 0.33% -0.018 pp | 1.34% +0.001 pp | USD92.54 +3.8% | 44 qtrs — |
| 45 | UBS GROUP AG | 4.17M -7.0M (-62.8%) | 400.66M -666.3M (-62.4%) | 0.33% -0.549 pp | 0.07% -0.102 pp | USD88.88 +8.1% | 44 qtrs — |
| 46 | BANK OF MONTREAL /CAN/ | 4.10M +2.0M (+98.8%) | 394.07M +197.5M (+100.5%) | 0.32% +0.159 pp | 0.14% +0.061 pp | USD92.01 +4.4% | 44 qtrs — |
| 47 | BESSEMER GROUP INC | 4.08M +1.5M (+60.6%) | 391.54M +149.8M (+62.0%) | 0.32% +0.120 pp | 0.60% +0.232 pp | USD93.71 +2.5% | 44 qtrs — |
| 48 | STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 3.62M +— (+0.0%) | 347.94M +3.0M (+0.9%) | 0.28% +0.000 pp | 0.27% -0.014 pp | USD81.39 +18.0% | 44 qtrs — |
| 49 | NEUBERGER BERMAN GROUP LLC | 3.58M +93.3K (+2.7%) | 343.50M +12.1M (+3.6%) | 0.28% +0.007 pp | 0.26% +0.014 pp | USD83.71 +14.8% | 44 qtrs — |
| 50 | SWISS NATIONAL BANK | 3.51M -178.4K (-4.8%) | 337.65M -14.1M (-4.0%) | 0.27% -0.014 pp | 0.20% -0.003 pp | USD84.99 +13.0% | 44 qtrs — |
| 51 | LAZARD ASSET MANAGEMENT LLC | 3.41M -2.6M (-43.1%) | 327.74M -243.8M (-42.7%) | 0.27% -0.202 pp | 0.56% -0.214 pp | USD88.19 +8.9% | 44 qtrs — |
| 52 | PZENA INVESTMENT MANAGEMENT LLC | 3.22M -2.7M (-45.7%) | 309.20M -255.4M (-45.2%) | 0.25% -0.211 pp | 0.93% -0.899 pp | USD82.12 +17.0% | 12 qtrs — |
| 53 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 3.18M -29.2K (-0.9%) | 305.66M -175.4K (-0.1%) | 0.25% -0.002 pp | 0.18% +0.004 pp | USD106.88 -10.1% | 16 qtrs — |
| 54 | JANUS HENDERSON GROUP PLC | 3.11M -438.0K (-12.3%) | 299.16M -39.1M (-11.6%) | 0.24% -0.034 pp | 0.13% -0.021 pp | USD94.81 +1.3% | 26 qtrs — |
| 55 | AQR CAPITAL MANAGEMENT LLC | 3.07M -260.3K (-7.8%) | 294.82M -19.6M (-6.2%) | 0.24% -0.020 pp | 0.15% -0.047 pp | USD89.83 +6.9% | 44 qtrs — |
| 56 | BNP PARIBAS ARBITRAGE, SNC | 2.99M +1.4M (+84.4%) | 287.44M +132.9M (+86.0%) | 0.23% +0.107 pp | 0.13% +0.048 pp | USD90.45 +6.2% | 44 qtrs — |
| 57 | NATIONAL PENSION SERVICE | 2.98M +28.3K (+1.0%) | 286.49M +5.1M (+1.8%) | 0.23% +0.002 pp | 0.21% -0.006 pp | USD87.50 +9.8% | 8 qtrs — |
| 58 | MILLENNIUM MANAGEMENT LLC | 2.98M -1.8M (-38.1%) | 285.83M -172.1M (-37.6%) | 0.23% -0.143 pp | 0.12% -0.075 pp | USD88.44 +8.6% | 44 qtrs — |
| 59 | NUVEEN, LLC | 2.86M -9.5K (-0.3%) | 274.68M +1.4M (+0.5%) | 0.22% -0.001 pp | 0.07% 0.000 pp | USD89.76 +7.0% | 4 qtrs — |
| 60 | GUINNESS ASSET MANAGEMENT LTD | 2.86M -75.2K (-2.6%) | 273.97M -1.6M (-0.6%) | 0.22% -0.006 pp | 4.44% +0.054 pp | USD95.24 +0.9% | 2 qtrs — |
| 61 | MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 2.76M +125.4K (+4.8%) | 264.82M +14.2M (+5.7%) | 0.22% +0.010 pp | 0.18% -0.001 pp | USD85.60 +12.2% | 44 qtrs — |
| 62 | NATIXIS ADVISORS, L.P. | 2.70M +78.0K (+3.0%) | 258.95M +9.6M (+3.9%) | 0.21% +0.006 pp | 0.37% +0.003 pp | USD87.16 +10.2% | 44 qtrs — |
| 63 | VAN ECK ASSOCIATES CORP | 2.61M +3.5K (+0.1%) | 250.81M +2.5M (+1.0%) | 0.20% +0.000 pp | 0.21% -0.023 pp | USD80.49 +19.3% | 37 qtrs — |
| 64 | FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 2.61M +43.7K (+1.7%) | 250.27M +6.3M (+2.6%) | 0.20% +0.003 pp | 1.33% +0.012 pp | USD88.03 +9.1% | 44 qtrs — |
| 65 | ABRDN PLC | 2.58M +28.9K (+1.1%) | 247.50M +7.1M (+2.9%) | 0.20% +0.002 pp | 0.38% +0.003 pp | USD85.50 +12.4% | 34 qtrs — |
| 66 | M&G PLC | 2.53M -308.4K (-10.9%) | 243.24M -26.8M (-9.9%) | 0.20% -0.024 pp | 1.25% -0.186 pp | USD87.05 +10.4% | 8 qtrs — |
| 67 | FMR LLC | 2.51M +145.3K (+6.1%) | 241.41M +15.9M (+7.0%) | 0.20% +0.011 pp | 0.01% +0.001 pp | USD93.89 +2.3% | 44 qtrs — |
| 68 | SG AMERICAS SECURITIES, LLC | 2.51M +2.4M (+2,222.3%) | 241.18M +230.9M (+2,242.2%) | 0.20% +0.187 pp | 0.31% +0.273 pp | USD95.79 +0.3% | 44 qtrs — |
| 69 | TRUIST FINANCIAL CORP | 2.51M +98.2K (+4.1%) | 240.93M +11.4M (+5.0%) | 0.20% +0.008 pp | 0.32% +0.011 pp | USD94.13 +2.1% | 44 qtrs — |
| 70 | CULLEN CAPITAL MANAGEMENT, LLC | 2.50M -177.2K (-6.6%) | 239.69M -14.8M (-5.8%) | 0.19% -0.014 pp | 2.62% -0.167 pp | USD82.98 +15.8% | 45 qtrs — |
| 71 | ALTRINSIC GLOBAL ADVISORS LLC | 2.48M -118.9K (-4.6%) | 238.63M -9.3M (-3.7%) | 0.19% -0.009 pp | 8.55% -0.614 pp | USD91.92 +4.5% | 44 qtrs — |
| 72 | MACKENZIE FINANCIAL CORP | 2.35M +398.8K (+20.5%) | 226.56M +40.9M (+22.0%) | 0.18% +0.031 pp | 0.27% +0.043 pp | USD88.51 +8.5% | 44 qtrs — |
| 73 | DIAMOND HILL CAPITAL MANAGEMENT INC | 2.31M -423.8K (-15.5%) | 221.67M -38.5M (-14.8%) | 0.18% -0.033 pp | 1.14% -0.099 pp | USD83.77 +14.7% | 45 qtrs — |
| 74 | RHUMBLINE ADVISERS | 2.28M -60.8K (-2.6%) | 219.16M -3.9M (-1.8%) | 0.18% -0.005 pp | 0.18% -0.002 pp | USD80.05 +20.0% | 45 qtrs — |
| 75 | USS INVESTMENT MANAGEMENT LTD | 2.28M +151.5K (+7.1%) | 218.67M +16.4M (+8.1%) | 0.18% +0.012 pp | 1.02% +0.097 pp | USD86.76 +10.7% | 27 qtrs — |
| 76 | BARCLAYS PLC | 2.24M -703.6K (-23.9%) | 215.27M -49.8M (-18.8%) | 0.17% -0.055 pp | 0.05% -0.016 pp | USD89.63 +7.2% | 44 qtrs — |
| 77 | GREAT WEST LIFE ASSURANCE CO /CAN/ | 2.19M -718.6K (-24.7%) | 210.92M -62.8M (-22.9%) | 0.17% -0.056 pp | 0.37% -0.025 pp | USD85.77 +12.0% | 44 qtrs — |
| 78 | DEKABANK DEUTSCHE GIROZENTRALE | 2.35M +— (+0.0%) | 208.37M -12.4M (-5.6%) | 0.18% 0.000 pp | 0.36% -0.011 pp | USD102.23 -6.0% | 35 qtrs — |
| 79 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2.09M -13.4K (-0.6%) | 200.95M +436.4K (+0.2%) | 0.16% -0.001 pp | 0.20% -0.005 pp | USD81.72 +17.5% | 44 qtrs — |
| 80 | THORNBURG INVESTMENT MANAGEMENT INC | 1.93M -1.6K (-0.1%) | 185.28M +1.4M (+0.8%) | 0.15% 0.000 pp | 2.34% -0.060 pp | USD82.28 +16.7% | 12 qtrs — |
| 81 | PROSHARE ADVISORS LLC | 1.91M -141.7K (-6.9%) | 183.64M -11.9M (-6.1%) | 0.15% -0.011 pp | 0.32% -0.085 pp | USD91.04 +5.5% | 44 qtrs — |
| 82 | ALLIANZ ASSET MANAGEMENT GMBH | 1.85M +370.4K (+25.1%) | 177.41M +36.8M (+26.2%) | 0.14% +0.029 pp | 0.18% +0.022 pp | USD89.26 +7.6% | 44 qtrs — |
| 83 | LPL FINANCIAL LLC | 1.77M +81.0K (+4.8%) | 170.38M +9.2M (+5.7%) | 0.14% +0.006 pp | 0.05% -0.001 pp | USD91.17 +5.4% | 44 qtrs — |
| 84 | PRINCIPAL FINANCIAL GROUP INC | 1.72M +64.1K (+3.9%) | 165.24M +7.5M (+4.8%) | 0.13% +0.005 pp | 0.08% +0.005 pp | USD86.56 +11.0% | 44 qtrs — |
| 85 | LAZARD FRERES GESTION S.A.S. | 1.71M +175.2K (+11.4%) | 163.87M +18.1M (+12.4%) | 0.13% +0.014 pp | 2.95% +0.177 pp | USD95.10 +1.0% | 21 qtrs — |
| 86 | RUSSELL INVESTMENTS GROUP, LTD. | 1.64M +83.6K (+5.4%) | 157.39M +9.4M (+6.4%) | 0.13% +0.007 pp | 0.17% +0.003 pp | USD88.58 +8.4% | 37 qtrs — |
| 87 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 1.63M +57.6K (+3.7%) | 156.49M +7.0M (+4.7%) | 0.13% +0.005 pp | 0.25% +0.006 pp | USD80.45 +19.4% | 5 qtrs — |
| 88 | VICTORY CAPITAL MANAGEMENT INC | 1.62M -10.7K (-0.7%) | 155.50M +311.2K (+0.2%) | 0.13% -0.001 pp | 0.09% -0.003 pp | USD91.87 +4.6% | 44 qtrs — |
| 89 | ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 1.60M +1.3M (+436.1%) | 153.50M +125.1M (+440.8%) | 0.12% +0.101 pp | 0.22% +0.178 pp | USD95.04 +1.1% | 44 qtrs — |
| 90 | BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 1.58M +64.5K (+4.2%) | 152.23M +7.4M (+5.1%) | 0.12% +0.005 pp | 1.02% +0.028 pp | USD90.65 +6.0% | 27 qtrs — |
| 91 | 1832 ASSET MANAGEMENT L.P. | 1.54M -230.3K (-13.0%) | 147.87M -20.7M (-12.3%) | 0.12% -0.018 pp | 0.11% -0.020 pp | USD83.14 +15.5% | 44 qtrs — |
| 92 | QUBE RESEARCH & TECHNOLOGIES LTD | 1.53M +1.5M (+10,779.4%) | 146.70M +145.4M (+10,873.0%) | 0.12% +0.118 pp | 0.15% +0.148 pp | USD95.95 +0.1% | 32 qtrs — |
| 93 | PEAK6 LLC | 1.53M +1.2M (+393.9%) | 146.65M +117.2M (+398.2%) | 0.12% +0.095 pp | 0.27% +0.230 pp | USD95.15 +1.0% | 5 qtrs — |
| 94 | EQUITY INVESTMENT CORP | 1.52M +2.5K (+0.2%) | 146.22M +1.5M (+1.0%) | 0.12% +0.000 pp | 2.95% -0.080 pp | USD79.69 +20.5% | 13 qtrs — |
| 95 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.52M -531.6K (-25.9%) | 146.20M -49.4M (-25.2%) | 0.12% -0.042 pp | 0.02% -0.006 pp | USD90.08 +6.6% | 44 qtrs — |
| 96 | NEW YORK STATE COMMON RETIREMENT FUND | 1.48M -15.6K (-1.0%) | 142.25M -271.5K (-0.2%) | 0.12% -0.001 pp | 0.19% +0.006 pp | USD79.79 +20.4% | 44 qtrs — |
| 97 | MAGELLAN ASSET MANAGEMENT LTD | 1.47M +146.2K (+11.0%) | 141.48M +15.1M (+12.0%) | 0.11% +0.011 pp | 1.72% +0.223 pp | USD95.32 +0.8% | 2 qtrs — |
| 98 | HIGHTOWER ADVISORS, LLC | 1.44M -15.7K (-1.1%) | 138.80M -309.7K (-0.2%) | 0.11% -0.001 pp | 0.15% -0.006 pp | USD100.37 -4.3% | 44 qtrs — |
| 99 | DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 1.43M +14.3K (+1.0%) | 137.67M +2.5M (+1.9%) | 0.11% +0.001 pp | 0.12% +0.001 pp | USD90.36 +6.3% | 37 qtrs — |
| 100 | ACADIAN ASSET MANAGEMENT LLC | 1.42M +762.5K (+116.4%) | 136.17M +73.8M (+118.2%) | 0.11% +0.060 pp | 0.22% +0.115 pp | USD91.65 +4.8% | 36 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.13
Neutral
Ratio by volume
1.24
Neutral
Buys
18
Sells
16
Shares acquired
190.0K
Shares disposed
153.4K
Cash buys
—
Cash sales
—
Net activity
+36,643
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | Walter Matthew R. | Officer | M-Exempt | A | Ordinary Shares | 9,149 | 0.00 | — | 41,529 | D | ↗ |
| 2026-05-26 | Wall Brett A. | Officer | M-Exempt | A | Ordinary Shares | 26,907 | 0.00 | — | 82,183 | D | ↗ |
| 2026-05-26 | Martha Geoffrey | Director / Officer | M-Exempt | A | Ordinary Shares | 94,963 | 0.00 | — | 343,099 | D | ↗ |
| 2026-05-26 | Marinaro Michael | Officer | M-Exempt | A | Ordinary Shares | 18,994 | 0.00 | — | 70,593 | D | ↗ |
| 2026-05-26 | KIIL HARRY SKIP | Officer | M-Exempt | A | Ordinary Shares | 15,195 | 0.00 | — | 48,233 | D | ↗ |
| 2026-05-26 | Blomquist Denise L. | Officer | M-Exempt | D | Performance Share Unit | 1,621 | 0.00 | — | 0 | D | ↗ |
| 2026-05-01 | Walter Matthew R. | Officer | F-InKind | D | Ordinary Shares | 35 | 80.00 | 2.8K | 32,380 | D | ↗ |
| 2026-04-28 | Powell Kendall J | Director | F-InKind | D | Ordinary Shares | 207 | 81.90 | 17.0K | 51,380 | D | ↗ |
| 2026-04-28 | NABEL ELIZABETH G | Director | F-InKind | D | Ordinary Shares | 207 | 81.90 | 17.0K | 19,584 | D | ↗ |
| 2026-04-28 | Lofton Kevin E | Director | F-InKind | D | Ordinary Shares | 207 | 81.90 | 17.0K | 10,140 | D | ↗ |
| 2026-04-28 | Lewis Gregory P | Director | F-InKind | D | Ordinary Shares | 207 | 81.90 | 17.0K | 5,754 | D | ↗ |
| 2026-04-28 | HOGAN RANDALL J | Director | F-InKind | D | Ordinary Shares | 207 | 81.90 | 17.0K | 48,998 | D | ↗ |
| 2026-04-28 | Fonseca Lidia | Director | F-InKind | D | Ordinary Shares | 207 | 81.90 | 17.0K | 7,644 | D | ↗ |
| 2026-04-28 | DONNELLY SCOTT C | Director | F-InKind | D | Ordinary Shares | 207 | 81.90 | 17.0K | 23,679 | D | ↗ |
| 2026-04-28 | Blomquist Denise L. | Officer | F-InKind | D | Ordinary Shares | 318 | 81.90 | 26.0K | 13,262 | D | ↗ |
| 2026-04-28 | ARNOLD CRAIG | Director | F-InKind | D | Ordinary Shares | 207 | 81.90 | 17.0K | 42,185 | D | ↗ |
| 2026-04-27 | Powell Kendall J | Director | A-Award | A | Ordinary Shares | 2,111 | 0.00 | — | 51,587 | D | ↗ |
| 2026-04-27 | NABEL ELIZABETH G | Director | A-Award | A | Ordinary Shares | 2,111 | 0.00 | — | 19,791 | D | ↗ |
| 2026-04-27 | Lofton Kevin E | Director | A-Award | A | Ordinary Shares | 2,111 | 0.00 | — | 10,347 | D | ↗ |
| 2026-04-27 | Lewis Gregory P | Director | A-Award | A | Ordinary Shares | 2,111 | 0.00 | — | 5,961 | D | ↗ |
| 2026-04-27 | Lee Joon Sup | Director | A-Award | A | Ordinary Shares | 1,803 | 0.00 | — | 1,803 | D | ↗ |
| 2026-04-27 | Jellison William R | Director | A-Award | A | Ordinary Shares | 1,444 | 0.00 | — | 6,444 | D | ↗ |
| 2026-04-27 | HOGAN RANDALL J | Director | A-Award | A | Ordinary Shares | 2,111 | 0.00 | — | 49,205 | D | ↗ |
| 2026-04-27 | Groetelaars John P | Director | A-Award | A | Ordinary Shares | 1,444 | 0.00 | — | 1,444 | D | ↗ |
| 2026-04-27 | Fonseca Lidia | Director | A-Award | A | Ordinary Shares | 2,111 | 0.00 | — | 7,851 | D | ↗ |
| 2026-04-27 | DONNELLY SCOTT C | Director | A-Award | A | Ordinary Shares | 2,111 | 0.00 | — | 23,886 | D | ↗ |
| 2026-04-27 | Blomquist Denise L. | Officer | A-Award | A | Ordinary Shares | 1,508 | 0.00 | — | 13,580 | D | ↗ |
| 2026-04-27 | ARNOLD CRAIG | Director | A-Award | A | Ordinary Shares | 2,111 | 0.00 | — | 42,392 | D | ↗ |
| 2026-03-03 | Pieton Thierry | Officer | F-InKind | D | Ordinary Shares | 2,976 | 96.71 | 287.8K | 37,574 | D | ↗ |
| 2026-02-20 | Blomquist Denise L. | Officer | G-Gift | D | Ordinary Shares | 340 | 0.00 | — | 11,966 | D | ↗ |
| 2026-02-19 | KIIL HARRY SKIP | Officer | S-Sale | D | Ordinary Shares | 19,255 | 97.77 | 1.88M | 33,821 | D | ↗ |
| 2026-01-29 | Blomquist Denise L. | Officer | F-InKind | D | Ordinary Shares | 148 | 101.00 | 14.9K | 12,306 | D | ↗ |
| 2025-12-15 | Wall Brett A. | Officer | F-InKind | D | Ordinary Shares | 439 | 99.87 | 43.8K | 54,749 | D | ↗ |
| 2025-12-15 | Martha Geoffrey | Director / Officer | F-InKind | D | Ordinary Shares | 1,564 | 99.87 | 156.2K | 246,393 | D | ↗ |
| 2025-12-15 | Marinaro Michael | Officer | F-InKind | D | Ordinary Shares | 1,371 | 99.87 | 136.9K | 50,818 | D | ↗ |
| 2025-12-05 | KIIL HARRY SKIP | Officer | F-InKind | D | Ordinary Shares | 1,702 | 101.36 | 172.5K | 34,177 | D | ↗ |
| 2025-11-20 | Blomquist Denise L. | Officer | G-Gift | D | Ordinary Shares | 170 | 0.00 | — | 12,357 | D | ↗ |
| 2025-11-19 | Smith Gregory L | Officer | S-Sale | D | Ordinary Shares | 24,186 | 101.93 | 2.47M | 51,830 | D | ↗ |
| 2025-09-03 | KIIL HARRY SKIP | Officer | S-Sale | D | Ordinary Shares | 8,405 | 91.58 | 769.7K | 35,815 | D | ↗ |
| 2025-08-25 | Jellison William R | Director | P-Purchase | A | Ordinary Shares | 2,500 | 92.37 | 230.9K | 5,000 | D | ↗ |
| 2025-08-22 | Jellison William R | Director | P-Purchase | A | Ordinary Shares | 2,500 | 92.73 | 231.8K | 2,500 | D | ↗ |
| 2025-08-20 | Marinaro Michael | Officer | F-InKind | D | Ordinary Shares | 1,052 | 93.22 | 98.1K | 51,939 | D | ↗ |
| 2025-08-19 | Jellison William R | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-08-19 | Groetelaars John P | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-08-01 | Walter Matthew R. | Officer | M-Exempt | A | Ordinary Shares | 2,179 | 0.00 | — | 32,804 | D | ↗ |
| 2025-08-01 | Wall Brett A. | Officer | F-InKind | D | Ordinary Shares | 3,850 | 89.34 | 344.0K | 54,937 | D | ↗ |
| 2025-08-01 | Smith Gregory L | Officer | M-Exempt | A | Ordinary Shares | 11,328 | 0.00 | — | 83,071 | D | ↗ |
| 2025-08-01 | Martha Geoffrey | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 40,600 | 78.00 | 3.17M | 0 | D | ↗ |
| 2025-08-01 | Marinaro Michael | Officer | M-Exempt | A | Ordinary Shares | 3,126 | 78.00 | 243.8K | 55,855 | D | ↗ |
| 2025-08-01 | KIIL HARRY SKIP | Officer | F-InKind | D | Ordinary Shares | 2,896 | 89.34 | 258.7K | 44,220 | D | ↗ |
| 2025-08-01 | Blomquist Denise L. | Officer | M-Exempt | A | Ordinary Shares | 246 | 0.00 | — | 12,671 | D | ↗ |
| 2025-07-31 | Smith Gregory L | Officer | F-InKind | D | Ordinary Shares | 1,630 | 90.24 | 147.1K | 71,743 | D | ↗ |
| 2025-07-29 | KIIL HARRY SKIP | Officer | — | — | Stock Option (Right to Buy) | 1,540 | 80.00 | 123.2K | 0 | D | ↗ |
| 2025-07-29 | Corona Gary Louis | Officer | — | D | Stock Option (Right to Buy) | 1,540 | 80.00 | 123.2K | 0 | — | ↗ |
| 2025-07-28 | Walter Matthew R. | Officer | A-Award | A | Ordinary Shares | 4,350 | 0.00 | — | 30,625 | D | ↗ |
| 2025-07-28 | Wall Brett A. | Officer | A-Award | A | Stock Option (Right to Buy) | 69,005 | 91.97 | 6.35M | 69,005 | D | ↗ |
| 2025-07-28 | Smith Gregory L | Officer | A-Award | A | Ordinary Shares | 9,786 | 0.00 | — | 73,373 | D | ↗ |
| 2025-07-28 | Quinn Michelle | Officer | A-Award | A | Ordinary Shares | 5,437 | 0.00 | — | 5,437 | D | ↗ |
| 2025-07-28 | Pieton Thierry | Officer | A-Award | A | Performance Share Units | 21,747 | 0.00 | — | 21,747 | D | ↗ |
| 2025-07-28 | Martha Geoffrey | Director / Officer | A-Award | A | Ordinary Shares | 37,513 | 0.00 | — | 225,976 | D | ↗ |
| 2025-07-28 | Marinaro Michael | Officer | A-Award | A | Performance Share Units | 24,465 | 0.00 | — | 24,465 | D | ↗ |
| 2025-07-28 | KIIL HARRY SKIP | Officer | A-Award | A | Stock Option (Right to Buy) | 53,671 | 91.97 | 4.94M | 53,671 | D | ↗ |
| 2025-07-28 | Blomquist Denise L. | Officer | A-Award | A | Performance Share Units | 2,202 | 0.00 | — | 2,202 | D | ↗ |
| 2025-07-21 | Quinn Michelle | Officer | — | — | Ordinary Shares | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-06-18 | Lee Joon Sup | Director | — | — | Ordinary Shares | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-06-03 | Blomquist Denise L. | Officer | G-Gift | D | Ordinary Shares | 310 | 0.00 | — | 10,143 | D | ↗ |
| 2025-05-21 | KIIL HARRY SKIP | Officer | — | — | Performance Share Unit | 15,378 | 0.00 | — | 0 | D | ↗ |
| 2025-05-02 | Walter Matthew R. | Officer | F-InKind | D | Ordinary Shares | 34 | 84.85 | 2.9K | 26,054 | D | ↗ |
| 2025-04-29 | Powell Kendall J | Director | F-InKind | D | Ordinary Shares | 216 | 84.60 | 18.3K | 48,622 | D | ↗ |
| 2025-04-29 | NABEL ELIZABETH G | Director | F-InKind | D | Ordinary Shares | 216 | 84.60 | 18.3K | 17,615 | D | ↗ |
| 2025-04-29 | Lofton Kevin E | Director | F-InKind | D | Ordinary Shares | 216 | 84.60 | 18.3K | 8,171 | D | ↗ |
| 2025-04-29 | Lewis Gregory P | Director | F-InKind | D | Ordinary Shares | 181 | 84.60 | 15.3K | 3,785 | D | ↗ |
| 2025-04-29 | HOGAN RANDALL J | Director | F-InKind | D | Ordinary Shares | 216 | 84.60 | 18.3K | 47,029 | D | ↗ |
| 2025-04-29 | Goldsmith Andrea Jo | Director | F-InKind | D | Ordinary Shares | 216 | 84.60 | 18.3K | 10,247 | D | ↗ |
| 2025-04-29 | Fonseca Lidia | Director | F-InKind | D | Ordinary Shares | 216 | 84.60 | 18.3K | 5,675 | D | ↗ |
| 2025-04-29 | DONNELLY SCOTT C | Director | F-InKind | D | Ordinary Shares | 216 | 84.60 | 18.3K | 21,630 | D | ↗ |
| 2025-04-29 | ARNOLD CRAIG | Director | F-InKind | D | Ordinary Shares | 216 | 84.60 | 18.3K | 40,216 | D | ↗ |
| 2025-04-28 | Powell Kendall J | Director | A-Award | A | Ordinary Shares | 2,083 | 84.04 | 175.1K | 48,838 | D | ↗ |
| 2025-04-28 | NABEL ELIZABETH G | Director | A-Award | A | Ordinary Shares | 2,083 | 84.04 | 175.1K | 17,831 | D | ↗ |
| 2025-04-28 | Lofton Kevin E | Director | A-Award | A | Ordinary Shares | 2,083 | 84.04 | 175.1K | 8,387 | D | ↗ |
| 2025-04-28 | Lewis Gregory P | Director | A-Award | A | Ordinary Shares | 2,083 | 84.04 | 175.1K | 3,966 | D | ↗ |
| 2025-04-28 | HOGAN RANDALL J | Director | A-Award | A | Ordinary Shares | 2,083 | 84.04 | 175.1K | 47,245 | D | ↗ |
| 2025-04-28 | Goldsmith Andrea Jo | Director | A-Award | A | Ordinary Shares | 2,083 | 84.04 | 175.1K | 10,463 | D | ↗ |
| 2025-04-28 | Fonseca Lidia | Director | A-Award | A | Ordinary Shares | 2,083 | 84.04 | 175.1K | 5,891 | D | ↗ |
| 2025-04-28 | DONNELLY SCOTT C | Director | A-Award | A | Ordinary Shares | 2,083 | 84.04 | 175.1K | 21,846 | D | ↗ |
| 2025-04-28 | Blomquist Denise L. | Officer | A-Award | A | Ordinary Shares | 2,975 | 0.00 | — | 10,453 | D | ↗ |
| 2025-04-28 | ARNOLD CRAIG | Director | A-Award | A | Ordinary Shares | 2,083 | 84.04 | 175.1K | 40,432 | D | ↗ |
| 2025-03-17 | Blomquist Denise L. | Officer | — | — | Performance Share Unit | 1,431 | 0.00 | — | 0 | D | ↗ |
| 2025-03-03 | Pieton Thierry | Officer | A-Award | A | Ordinary Shares | 26,512 | 0.00 | — | 30,754 | D | ↗ |
| 2025-03-03 | Marinaro Michael | Officer | F-InKind | D | Ordinary Shares | 575 | 94.30 | 54.2K | 40,675 | D | ↗ |
| 2025-01-27 | Walter Matthew R. | Officer | M-Exempt | A | Ordinary Shares | 1,337 | 74.84 | 100.1K | 26,997 | D | ↗ |
| 2025-01-27 | Martha Geoffrey | Director / Officer | M-Exempt | A | Ordinary Shares | 34,741 | 74.84 | 2.60M | 216,954 | D | ↗ |
| 2025-01-27 | Marinaro Michael | Officer | F-InKind | D | Ordinary Shares | 2,073 | 92.46 | 191.7K | 41,250 | D | ↗ |
| 2025-01-24 | Wall Brett A. | Officer | S-Sale | D | Ordinary Shares | 12,437 | 90.00 | 1.12M | 40,979 | D | ↗ |
| 2025-01-21 | Corona Gary Louis | Officer | A-Award | A | Ordinary Shares | 11,315 | 0.00 | — | 44,255 | D | ↗ |
| 2025-01-08 | Wall Brett A. | Officer | M-Exempt | D | Stock Option (Right to Buy) | 6,850 | 74.84 | 512.7K | 0 | D | ↗ |
| 2024-12-16 | Wall Brett A. | Officer | F-InKind | D | Ordinary Shares | 645 | 82.48 | 53.2K | 43,708 | D | ↗ |
| 2024-12-16 | Salmon Sean | Officer | F-InKind | D | Ordinary Shares | 645 | 82.48 | 53.2K | 64,722 | D | ↗ |
| 2024-12-16 | Martha Geoffrey | Director / Officer | F-InKind | D | Ordinary Shares | 4,417 | 82.48 | 364.3K | 181,326 | D | ↗ |
| 2024-12-16 | Fong Ivan K | Officer | F-InKind | D | Ordinary Shares | 532 | 82.48 | 43.9K | 54,692 | D | ↗ |
| 2024-12-10 | Fong Ivan K | Officer | F-InKind | D | Ordinary Shares | 3,009 | 83.58 | 251.5K | 55,224 | D | ↗ |
| 2024-12-06 | Kirk Jennifer M | Officer | F-InKind | D | Ordinary Shares | 646 | 84.01 | 54.3K | 28,011 | D | ↗ |
| 2024-12-06 | Corona Gary Louis | Officer | F-InKind | D | Ordinary Shares | 662 | 84.01 | 55.6K | 32,721 | D | ↗ |
| 2024-08-20 | Marinaro Michael | Officer | F-InKind | D | Ordinary Shares | 2,045 | 85.38 | 174.6K | 40,346 | — | ↗ |
| 2024-08-15 | Corona Gary Louis | Officer | A-Award | A | Ordinary Shares | 8,966 | 0.00 | — | 33,035 | — | ↗ |
| 2024-08-03 | Corona Gary Louis | Officer | — | D | Ordinary Shares | 0 | 0.00 | — | 24,069 | — | ↗ |
| 2024-08-02 | Walter Matthew R. | Officer | M-Exempt | D | Performance Share Unit | 684 | 0.00 | — | 0 | — | ↗ |
| 2024-08-02 | Wall Brett A. | Officer | M-Exempt | D | Performance Share Units | 5,311 | 0.00 | — | 0 | — | ↗ |
| 2024-08-02 | Smith Gregory L | Officer | M-Exempt | D | Performance Share Units | 3,490 | 0.00 | — | 0 | — | ↗ |
| 2024-08-02 | Salmon Sean | Officer | M-Exempt | D | Performance Share Units | 5,462 | 0.00 | — | 0 | — | ↗ |
| 2024-08-02 | PARKHILL KAREN L | Officer | F-InKind | D | Ordinary Shares | 3,581 | 81.51 | 291.9K | 46,730 | — | ↗ |
| 2024-08-02 | Martha Geoffrey | Director / Officer | M-Exempt | A | Ordinary Shares | 18,966 | 0.00 | — | 203,086 | — | ↗ |
| 2024-08-02 | Marinaro Michael | Officer | M-Exempt | A | Ordinary Shares | 1,670 | 0.00 | — | 43,801 | — | ↗ |
| 2024-08-02 | Kirk Jennifer M | Officer | M-Exempt | D | Performance Share Units | 1,138 | 0.00 | — | 0 | — | ↗ |
| 2024-08-02 | Fong Ivan K | Officer | M-Exempt | D | Performance Share Units | 6,144 | 0.00 | — | 0 | — | ↗ |
| 2024-07-31 | Walter Matthew R. | Officer | — | D | Stock Option (Right to Buy) | 24,525 | 87.76 | 2.15M | 0 | — | ↗ |
| 2024-07-31 | Smith Gregory L | Officer | F-InKind | D | Ordinary Shares | 1,406 | 80.32 | 112.9K | 61,267 | — | ↗ |
| 2024-07-31 | KIIL HARRY SKIP | Officer | — | — | Stock Option (Right to Buy) | 38,849 | 87.76 | 3.41M | 0 | D | ↗ |
| 2024-07-31 | Corona Gary Louis | Officer | — | D | Stock Option (Right to Buy) | 10,164 | 87.76 | 892.0K | 0 | — | ↗ |
| 2024-07-31 | Blomquist Denise L. | Officer | — | — | Stock Option (Right to Buy) | 4,333 | 87.76 | 380.3K | 0 | D | ↗ |
| 2024-07-29 | Walter Matthew R. | Officer | A-Award | A | Performance Share Unit | 19,063 | 0.00 | — | 19,063 | — | ↗ |
| 2024-07-29 | Wall Brett A. | Officer | A-Award | A | Ordinary Shares | 14,375 | 0.00 | — | 43,858 | — | ↗ |
| 2024-07-29 | Smith Gregory L | Officer | A-Award | A | Ordinary Shares | 14,375 | 0.00 | — | 62,673 | — | ↗ |
| 2024-07-29 | Salmon Sean | Officer | A-Award | A | Ordinary Shares | 14,375 | 0.00 | — | 63,084 | — | ↗ |
| 2024-07-29 | Martha Geoffrey | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 295,680 | 80.00 | 23.65M | 295,680 | — | ↗ |
| 2024-07-29 | Marinaro Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 101,640 | 80.00 | 8.13M | 101,640 | — | ↗ |
| 2024-07-29 | Kirk Jennifer M | Officer | A-Award | A | Ordinary Shares | 7,813 | 0.00 | — | 21,516 | — | ↗ |
| 2024-07-29 | Fong Ivan K | Officer | A-Award | A | Stock Option (Right to Buy) | 94,248 | 80.00 | 7.54M | 92,248 | — | ↗ |
| 2024-07-18 | Walter Matthew R. | Officer | M-Exempt | D | Stock Option (Right to Buy) | 492 | 62.76 | 30.9K | 0 | — | ↗ |
| 2024-06-24 | Walter Matthew R. | Officer | — | D | Performance Share Unit | 8,449 | 0.00 | — | 0 | — | ↗ |
| 2024-06-07 | Martha Geoffrey | Director / Officer | M-Exempt | A | Ordinary Shares | 1,594 | 62.76 | 100.0K | 162,461 | — | ↗ |
| 2024-05-01 | Powell Kendall J | Director | F-InKind | D | Ordinary Shares | 192 | 80.89 | 15.5K | 45,843 | — | ↗ |
| 2024-05-01 | OLEARY DENISE M | Director | F-InKind | D | Ordinary Shares | 192 | 80.89 | 15.5K | 77,057 | — | ↗ |
| 2024-05-01 | NABEL ELIZABETH G | Director | F-InKind | D | Ordinary Shares | 192 | 80.89 | 15.5K | 15,674 | — | ↗ |
| 2024-05-01 | Lofton Kevin E | Director | F-InKind | D | Ordinary Shares | 192 | 80.89 | 15.5K | 6,230 | — | ↗ |
| 2024-05-01 | HOGAN RANDALL J | Director | F-InKind | D | Ordinary Shares | 192 | 80.89 | 15.5K | 45,088 | — | ↗ |
| 2024-05-01 | Goldsmith Andrea Jo | Director | F-InKind | D | Ordinary Shares | 192 | 80.89 | 15.5K | 8,306 | — | ↗ |
| 2024-05-01 | Fonseca Lidia | Director | F-InKind | D | Ordinary Shares | 162 | 80.89 | 13.1K | 3,682 | — | ↗ |
| 2024-05-01 | DONNELLY SCOTT C | Director | F-InKind | D | Ordinary Shares | 192 | 80.89 | 15.5K | 19,604 | — | ↗ |
| 2024-05-01 | ARNOLD CRAIG | Director | F-InKind | D | Ordinary Shares | 192 | 80.89 | 15.5K | 38,275 | — | ↗ |
| 2024-04-29 | Powell Kendall J | Director | A-Award | A | Ordinary Shares | 2,165 | 80.86 | 175.1K | 46,035 | — | ↗ |
| 2024-04-29 | OLEARY DENISE M | Director | A-Award | A | Ordinary Shares | 2,165 | 80.86 | 175.1K | 77,249 | — | ↗ |
| 2024-04-29 | NABEL ELIZABETH G | Director | A-Award | A | Ordinary Shares | 2,165 | 80.86 | 175.1K | 15,866 | — | ↗ |
| 2024-04-29 | Lofton Kevin E | Director | A-Award | A | Ordinary Shares | 2,165 | 80.86 | 175.1K | 6,422 | — | ↗ |
| 2024-04-29 | Lewis Gregory P | Director | A-Award | A | Ordinary Shares | 1,821 | 80.86 | 147.2K | 1,821 | — | ↗ |
| 2024-04-29 | HOGAN RANDALL J | Director | A-Award | A | Ordinary Shares | 2,165 | 80.86 | 175.1K | 45,280 | — | ↗ |
| 2024-04-29 | Goldsmith Andrea Jo | Director | A-Award | A | Ordinary Shares | 2,165 | 80.86 | 175.1K | 8,498 | — | ↗ |
| 2024-04-29 | Fonseca Lidia | Director | A-Award | A | Ordinary Shares | 2,165 | 80.86 | 175.1K | 3,844 | — | ↗ |
| 2024-04-29 | DONNELLY SCOTT C | Director | A-Award | A | Ordinary Shares | 2,165 | 80.86 | 175.1K | 19,796 | — | ↗ |
| 2024-04-29 | ARNOLD CRAIG | Director | A-Award | A | Ordinary Shares | 2,165 | 80.86 | 175.1K | 38,467 | — | ↗ |
| 2024-04-08 | Marinaro Michael | Officer | S-Sale | D | Ordinary Shares | 854 | 83.14 | 71.0K | 27,925 | — | ↗ |
| 2024-03-05 | Marinaro Michael | Officer | F-InKind | D | Ordinary Shares | 563 | 83.60 | 47.1K | 28,779 | — | ↗ |
| 2024-02-21 | Salmon Sean | Officer | S-Sale | D | Ordinary Shares | 16,035 | 85.12 | 1.36M | 48,289 | — | ↗ |
| 2024-02-01 | Kirk Jennifer M | Officer | F-InKind | D | Ordinary Shares | 1,159 | 88.09 | 102.1K | 13,208 | — | ↗ |
| 2023-12-19 | Wall Brett A. | Officer | S-Sale | D | Ordinary Shares | 4,997 | 82.17 | 410.6K | 28,910 | — | ↗ |
| 2023-12-11 | Fong Ivan K | Officer | F-InKind | D | Ordinary Shares | 1,952 | 79.35 | 154.9K | 39,201 | — | ↗ |
| 2023-12-08 | Wall Brett A. | Officer | F-InKind | D | Ordinary Shares | 435 | 79.27 | 34.5K | 33,907 | — | ↗ |
| 2023-12-08 | WHITE ROBERT JOHN | Officer | F-InKind | D | Ordinary Shares | 369 | 79.27 | 29.3K | 48,410 | — | ↗ |
| 2023-12-08 | Salmon Sean | Officer | F-InKind | D | Ordinary Shares | 435 | 79.27 | 34.5K | 48,103 | — | ↗ |
| 2023-12-08 | Fong Ivan K | Officer | F-InKind | D | Ordinary Shares | 716 | 79.27 | 56.8K | 40,091 | — | ↗ |
| 2023-10-31 | Blomquist Denise L. | Officer | — | — | Stock Option (Right to Buy) | 769 | 87.34 | 67.2K | 0 | D | ↗ |
| 2023-10-30 | Kirk Jennifer M | Officer | A-Award | A | Stock Option (Right to Buy) | 1,695 | 69.97 | 118.6K | 1,695 | — | ↗ |
| 2023-08-23 | Smith Gregory L | Officer | S-Sale | D | Ordinary Shares | 10,000 | 83.84 | 838.4K | 46,723 | — | ↗ |
| 2023-08-14 | Wall Brett A. | Officer | S-Sale | D | Ordinary Shares | 1,000 | 83.38 | 83.4K | 33,573 | — | ↗ |
| 2023-08-04 | Marinaro Michael | Officer | S-Sale | D | Ordinary Shares | 1,352 | 84.11 | 113.7K | 28,930 | — | ↗ |
| 2023-08-03 | Wall Brett A. | Officer | M-Exempt | D | Performance Share Units | 5,168 | 0.00 | — | 0 | — | ↗ |
| 2023-08-03 | WHITE ROBERT JOHN | Officer | M-Exempt | D | Performance Share Units | 5,813 | 0.00 | — | 0 | — | ↗ |
| 2023-08-03 | TEN HOEDT ROB | Officer | M-Exempt | D | Performance Share Units | 4,251 | 0.00 | — | 0 | — | ↗ |
| 2023-08-03 | Smith Gregory L | Officer | M-Exempt | D | Performance Share Units | 6,217 | 0.00 | — | 0 | — | ↗ |
| 2023-08-03 | Salmon Sean | Officer | M-Exempt | D | Performance Share Units | 5,604 | 0.00 | — | 0 | — | ↗ |
| 2023-08-03 | PARKHILL KAREN L | Officer | M-Exempt | D | Performance Share Units | 7,105 | 0.00 | — | 0 | — | ↗ |
| 2023-08-03 | Martha Geoffrey | Director / Officer | M-Exempt | D | Performance Share Units | 18,165 | 0.00 | — | 0 | — | ↗ |
| 2023-08-03 | Marinaro Michael | Officer | M-Exempt | D | Performance Share Unit | 1,696 | 0.00 | — | 0 | — | ↗ |
| 2023-08-03 | Kirk Jennifer M | Officer | A-Award | A | Ordinary Shares | 1,178 | 0.00 | — | 14,554 | — | ↗ |
| 2023-08-01 | Walter Matthew R. | Officer | — | D | Stock Option (Right to Buy) | 9,908 | 93.08 | 922.2K | 0 | — | ↗ |
| 2023-08-01 | Marinaro Michael | Officer | — | D | Stock Option (Right to Buy) | 26,890 | 93.08 | 2.50M | 0 | — | ↗ |
| 2023-08-01 | KIIL HARRY SKIP | Officer | — | — | Stock Option (Right to Buy) | 42,174 | 93.08 | 3.93M | 0 | D | ↗ |
| 2023-08-01 | Blomquist Denise L. | Officer | — | — | Stock Option (Right to Buy) | 3,821 | 93.08 | 355.7K | 0 | D | ↗ |
| 2023-07-31 | Wall Brett A. | Officer | A-Award | A | Ordinary Shares | 9,686 | 0.00 | — | 33,634 | — | ↗ |
| 2023-07-31 | WHITE ROBERT JOHN | Officer | A-Award | A | Performance Share Units | 22,790 | 0.00 | — | 22,790 | — | ↗ |
| 2023-07-31 | TEN HOEDT ROB | Officer | A-Award | A | Stock Option (Right to Buy) | 60,173 | 87.76 | 5.28M | 60,173 | — | ↗ |
| 2023-07-31 | Smith Gregory L | Officer | A-Award | A | Stock Option (Right to Buy) | 64,185 | 87.76 | 5.63M | 64,185 | — | ↗ |
| 2023-07-31 | Salmon Sean | Officer | A-Award | A | Stock Option (Right to Buy) | 68,196 | 87.76 | 5.98M | 68,196 | — | ↗ |
| 2023-07-31 | PARKHILL KAREN L | Officer | A-Award | A | Ordinary Shares | 12,535 | 0.00 | — | 44,418 | — | ↗ |
| 2023-07-31 | Martha Geoffrey | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 240,691 | 87.76 | 21.12M | 481,382 | — | ↗ |
| 2023-07-31 | Marinaro Michael | Officer | A-Award | A | Stock Option (Right to Buy) | 48,139 | 87.76 | 4.22M | 48,139 | — | ↗ |
| 2023-07-31 | Kirk Jennifer M | Officer | A-Award | A | Performance Share Units | 7,122 | 0.00 | — | 7,122 | — | ↗ |
| 2023-07-31 | Fong Ivan K | Officer | A-Award | A | Stock Option (Right to Buy) | 56,162 | 87.76 | 4.93M | 56,162 | — | ↗ |
| 2023-07-14 | Wall Brett A. | Officer | S-Sale | D | Ordinary Shares | 2,000 | 87.97 | 175.9K | 23,948 | — | ↗ |
| 2023-07-10 | TEN HOEDT ROB | Officer | M-Exempt | A | Ordinary Shares | 3,706 | 55.32 | 205.0K | 47,508 | — | ↗ |
| 2023-06-26 | Marinaro Michael | Officer | — | D | Performance Share Unit | 8,058 | 0.00 | — | 0 | — | ↗ |
| 2023-06-26 | Lewis Gregory P | Director | — | D | Ordinary Shares | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-05-02 | Powell Kendall J | Director | F-InKind | D | Ordinary Shares | 169 | 90.23 | 15.2K | 39,992 | — | ↗ |
| 2023-05-02 | OLEARY DENISE M | Director | F-InKind | D | Ordinary Shares | 169 | 90.23 | 15.2K | 73,838 | — | ↗ |
| 2023-05-02 | NABEL ELIZABETH G | Director | F-InKind | D | Ordinary Shares | 169 | 90.23 | 15.2K | 13,635 | — | ↗ |
| 2023-05-02 | Lofton Kevin E | Director | F-InKind | D | Ordinary Shares | 169 | 90.23 | 15.2K | 4,191 | — | ↗ |
| 2023-05-02 | HOGAN RANDALL J | Director | F-InKind | D | Ordinary Shares | 169 | 90.23 | 15.2K | 5,964 | — | ↗ |
| 2023-05-02 | Goldsmith Andrea Jo | Director | F-InKind | D | Ordinary Shares | 169 | 90.23 | 15.2K | 6,267 | — | ↗ |
| 2023-05-02 | DONNELLY SCOTT C | Director | F-InKind | D | Ordinary Shares | 169 | 90.23 | 15.2K | 16,576 | — | ↗ |
| 2023-05-02 | ARNOLD CRAIG | Director | F-InKind | D | Ordinary Shares | 169 | 90.23 | 15.2K | 36,236 | — | ↗ |
Executive team
Top executives
Shares Outstanding
1.28B
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Geoffrey S. Martha Chairman and Chief Executive Officer | 1.35M | — | 12.63M | 4.80M | 1.88M | 581.4K | 21.24M | 82.04% | ↗ |
| 2 | 2025 | Sean M. Salmon Former EVP & President, Cardiovascular Portfolio | 884.7K | — | 4.54M | 1.73M | 823.1K | 426.6K | 8.40M | 74.58% | ↗ |
| 3 | 2025 | Brett A. Wall EVP & President, Neuroscience Portfolio | 774.5K | — | 4.54M | 1.73M | 720.8K | 363.7K | 8.12M | 77.11% | ↗ |
| 4 | 2025 | Gregory L. Smith EVP Enterprise Operations | 894.6K | — | 4.54M | 1.73M | 832.4K | 94.8K | 8.08M | 77.47% | ↗ |
| 5 | 2025 | Thierry Piéton Executive Vice President and Chief Financial Officer | 138.5K | — | 4.19M | 600.1K | 142.0K | 141.3K | 5.21M | 91.91% | ↗ |
| 6 | 2025 | Gary L. Corona Former SVP Corporate Finance (former Interim CFO) | 466.3K | — | 3.09M | 25.0K | — | 214.8K | 3.80M | 82.05% | ↗ |
| 7 | 2025 | Karen L. Parkhill Former Executive Vice President and Chief Financial Officer | 262.9K | — | — | — | — | 7.8K | 270.7K | 0.00% | ↗ |
| 8 | 2024 | Geoffrey S. Martha Chairman and Chief Executive Officer | 1.35M | — | 12.02M | 4.50M | 1.91M | 305.5K | 20.08M | 82.27% | ↗ |
| 9 | 2024 | Robert J. White Former EVP & President, Medical Surgical Portfolio | 794.5K | — | 3.21M | 1.20M | 794.5K | 3.32M | 9.31M | 47.31% | ↗ |
| 10 | 2024 | Karen L. Parkhill Former Executive Vice President and Chief Financial Officer | 911.2K | — | 4.41M | 1.65M | 943.1K | 66.2K | 7.98M | 75.93% | ↗ |
| 11 | 2024 | Gregory L. Smith EVP Enterprise Operations | 872.1K | — | 4.71M | 1.20M | 820.5K | 65.0K | 7.66M | 77.07% | ↗ |
| 12 | 2024 | Gregory L. Smith EVP Global Operations and Supply Chain | 872.1K | — | 4.71M | 1.20M | 820.5K | 65.0K | 7.66M | 77.07% | ↗ |
| 13 | 2024 | Sean M. Salmon Former EVP & President, Cardiovascular Portfolio | 867.0K | — | 3.41M | 1.27M | 775.0K | 225.0K | 6.55M | 71.49% | ↗ |
| 14 | 2024 | Sean M. Salmon EVP & President, Cardiovascular Portfolio | 867.0K | — | 3.41M | 1.27M | 775.0K | 225.0K | 6.55M | 71.49% | ↗ |
| 15 | 2024 | Brett A. Wall EVP & President, Neuroscience Portfolio | 749.4K | — | 3.41M | 1.27M | 670.6K | 334.3K | 6.44M | 72.74% | ↗ |
| 16 | 2023 | Geoffrey S. Martha Chairman and Chief Executive Officer | 1.35M | — | 9.63M | 3.98M | — | 443.6K | 15.39M | 88.35% | ↗ |
| 17 | 2023 | Karen L. Parkhill Executive Vice President and Chief Financial Officer | 911.1K | — | 3.63M | 1.50M | — | 81.2K | 6.12M | 83.80% | ↗ |
| 18 | 2023 | Karen L. Parkhill Former Executive Vice President and Chief Financial Officer | 911.1K | — | 3.63M | 1.50M | — | 81.2K | 6.12M | 83.80% | ↗ |
| 19 | 2023 | Sean M. Salmon Former EVP & President, Cardiovascular Portfolio | 867.0K | — | 2.91M | 1.20M | — | 391.7K | 5.36M | 76.54% | ↗ |
| 20 | 2023 | Sean M. Salmon EVP & President, Cardiovascular Portfolio | 867.0K | — | 2.91M | 1.20M | — | 391.7K | 5.36M | 76.54% | ↗ |
| 21 | 2023 | Rob ten Hoedt EVP & President, Global Regions | 907.4K | 269.6K | 2.47M | 1.02M | — | 380.6K | 5.05M | 69.14% | ↗ |
| 22 | 2023 | Robert J. White EVP & President, Medical Surgical Portfolio | 794.5K | — | 2.91M | 1.20M | — | 130.7K | 5.03M | 81.61% | ↗ |
| 23 | 2023 | Robert J. White Former EVP & President, Medical Surgical Portfolio | 794.5K | — | 2.91M | 1.20M | — | 130.7K | 5.03M | 81.61% | ↗ |
| 24 | 2022 | Ivan Fong Executive Vice President, General Counsel and Secretary | 189.5K | 650.0K | 6.96M | 3.77M | 129.1K | 17.0K | 23.43M | 45.79% | ↗ |
| 25 | 2022 | Geoffrey S. Martha Chairman and Chief Executive Officer | 1.35M | — | 9.76M | 3.75M | 2.55M | 450.5K | 17.86M | 75.65% | ↗ |
| 26 | 2022 | Robert J. White Executive Vice President, Medical Surgical Portfolio | 794.0K | — | 2.80M | 1.23M | 1.09M | 112.8K | 11.46M | 35.14% | ↗ |
| 27 | 2022 | Bradley E. Lerman Former Senior Vice President, General Counsel and Secretary | 699.0K | — | 2.77M | 1.21M | 904.4K | 97.7K | 10.86M | 36.59% | ↗ |
| 28 | 2022 | Rob ten Hoedt EVP & President, Europe, Middle East & Africa Region, and Asia Pacific | 881.3K | — | 2.38M | 1.05M | 1.08M | 279.4K | 10.86M | 31.53% | ↗ |
| 29 | 2022 | Karen L. Parkhill Former Executive Vice President and Chief Financial Officer | 901.5K | — | 3.67M | 1.44M | 1.42M | 90.6K | 7.52M | 67.91% | ↗ |
| 30 | 2022 | Karen L. Parkhill Executive Vice President and Chief Financial Officer | 901.5K | — | 3.67M | 1.44M | 1.42M | 90.6K | 7.52M | 67.91% | ↗ |
| 31 | 2022 | Robert J. White EVP & President, Medical Surgical Portfolio | 794.0K | — | 3.12M | 1.23M | 1.09M | 115.7K | 6.35M | 68.45% | ↗ |
| 32 | 2022 | Robert J. White Former EVP & President, Medical Surgical Portfolio | 794.0K | — | 3.12M | 1.23M | 1.09M | 115.7K | 6.35M | 68.45% | ↗ |
| 33 | 2022 | Rob ten Hoedt EVP & President, Global Regions | 881.3K | — | 2.66M | 1.05M | 1.08M | 279.4K | 5.94M | 62.31% | ↗ |
| 34 | 2021 | Geoffrey S. Martha Chairman and Chief Executive Officer | 1.14M | — | 8.91M | 4.50M | 2.74M | 209.3K | 17.51M | 76.63% | ↗ |
| 35 | 2021 | Michael J. Coyle Former Executive Vice President and Group President, CVG | 682.4K | — | 3.22M | 2.18M | 2.08M | 54.8K | 15.02M | 35.98% | ↗ |
| 36 | 2021 | Bradley E. Lerman Senior Vice President, General Counsel and Corporate Secretary | 907.7K | — | 2.77M | 1.83M | 1.83M | 87.1K | 13.76M | 33.40% | ↗ |
| 37 | 2021 | Bradley E. Lerman Former Senior Vice President, General Counsel and Secretary | 907.7K | — | 2.77M | 1.83M | 1.83M | 87.1K | 13.76M | 33.40% | ↗ |
| 38 | 2021 | Robert J. White Executive Vice President, Medical Surgical Portfolio | 793.4K | — | 2.52M | 1.75M | 1.78M | 81.4K | 12.82M | 33.26% | ↗ |
| 39 | 2021 | Omar Ishrak Former Executive Chairman and Chief Executive Officer | 701.7K | — | — | 2.53M | 5.03M | 89.0K | 12.37M | 20.45% | ↗ |
| 40 | 2021 | Richard E. Kuntz Senior Vice President, Chief Medical and Scientific Officer | 851.0K | — | 2.24M | 1.57M | 1.68M | 84.3K | 11.85M | 32.10% | ↗ |
| 41 | 2021 | Karen L. Parkhill Executive Vice President and Chief Financial Officer | 900.9K | — | 3.49M | 2.15M | 2.32M | 68.7K | 8.92M | 63.10% | ↗ |
| 42 | 2021 | Robert J. White EVP & President, Medical Surgical Portfolio | 793.4K | — | 2.85M | 1.75M | 1.78M | 83.0K | 7.25M | 63.36% | ↗ |
| 43 | 2020 | Omar Ishrak Former Executive Chairman and Chief Executive Officer | 1.74M | — | 4.67M | 4.67M | 3.38M | 366.0K | 30.93M | 30.17% | ↗ |
| 44 | 2020 | Omar Ishrak Chairman and Chief Executive Officer | 1.74M | — | 4.67M | 4.67M | 3.38M | 366.0K | 14.82M | 62.96% | ↗ |
| 45 | 2020 | Geoffrey S. Martha Chairman and Chief Executive Officer | 905.3K | — | 2.30M | 2.32M | 626.3K | 149.4K | 14.29M | 32.38% | ↗ |
| 46 | 2020 | Michael J. Coyle Former Executive Vice President and Group President, CVG | 933.4K | — | 1.53M | 1.56M | 1.03M | 131.5K | 10.87M | 28.43% | ↗ |
| 47 | 2020 | Karen L. Parkhill Executive Vice President and Chief Financial Officer | 865.9K | — | 1.47M | 1.49M | 851.8K | 90.4K | 10.15M | 29.15% | ↗ |
| 48 | 2020 | Bradley E. Lerman Senior Vice President, General Counsel and Corporate Secretary | 873.1K | — | 1.07M | 1.09M | 751.6K | 117.6K | 8.12M | 26.59% | ↗ |
| 49 | 2020 | Bradley E. Lerman Former Senior Vice President, General Counsel and Secretary | 873.1K | — | 1.07M | 1.09M | 751.6K | 117.6K | 8.12M | 26.59% | ↗ |
| 50 | 2020 | Geoffrey S. Martha President | 905.3K | — | 2.30M | 2.32M | 626.3K | 149.4K | 6.31M | 73.34% | ↗ |
| 51 | 2020 | Michael J. Coyle Executive Vice President and Group President, Cardiac and Vascular Group | 933.4K | — | 1.53M | 1.56M | 1.03M | 131.5K | 5.18M | 59.64% | ↗ |
| 52 | 2020 | Hooman C. Hakami Former Executive Vice President and President, Diabetes | 608.9K | — | 833.4K | 858.3K | — | 2.87M | 5.17M | 32.71% | ↗ |
| 53 | 2019 | Omar Ishrak Former Executive Chairman and Chief Executive Officer | 1.69M | — | 4.50M | 4.50M | 6.75M | 356.7K | 36.53M | 24.64% | ↗ |
| 54 | 2019 | Omar Ishrak Chairman and Chief Executive Officer | 1.69M | — | 4.50M | 4.50M | 6.75M | 356.7K | 17.80M | 50.57% | ↗ |
| 55 | 2019 | Michael J. Coyle Former Executive Vice President and Group President, CVG | 923.5K | — | 1.47M | 1.49M | 2.08M | 123.0K | 12.55M | 23.58% | ↗ |
| 56 | 2019 | Karen L. Parkhill Executive Vice President and Chief Financial Officer | 825.6K | — | 1.26M | 1.28M | 1.77M | 84.7K | 10.89M | 23.28% | ↗ |
| 57 | 2019 | Bradley E. Lerman Senior Vice President, General Counsel and Corporate Secretary | 847.4K | — | 1.00M | 1.03M | 1.57M | 109.7K | 9.31M | 21.76% | ↗ |
| 58 | 2019 | Geoffrey S. Martha Chairman and Chief Executive Officer | 692.5K | — | 1.00M | 1.03M | 1.35M | 101.0K | 8.73M | 23.19% | ↗ |
| 59 | 2019 | Michael J. Coyle Executive Vice President and Group President, Cardiac and Vascular Group | 923.5K | — | 1.47M | 1.49M | 2.08M | 123.0K | 6.08M | 48.65% | ↗ |
| 60 | 2019 | Geoffrey S. Martha Group President, Restorative Therapies Group | 692.5K | — | 1.00M | 1.03M | 1.35M | 101.0K | 4.17M | 48.55% | ↗ |
| 61 | 2019 | Geoffrey S. Martha President | 692.5K | — | 1.00M | 1.03M | 1.35M | 101.0K | 4.17M | 48.55% | ↗ |
| 62 | 2018 | Omar Ishrak Chairman and Chief Executive Officer | 1.64M | — | 4.50M | 2.94M | 8.11M | 391.1K | 17.59M | 42.33% | ↗ |
| 63 | 2018 | Rob ten Hoedt Executive Vice President & President Europe, Middle East and Africa Region | 806.1K | — | 766.7K | 517.8K | 1.71M | 2.70M | 6.50M | 19.76% | ↗ |
| 64 | 2018 | Michael J. Coyle Executive Vice President & Group President Cardiac and Vascular Group | 896.9K | — | 1.37M | 910.2K | 2.36M | 121.1K | 5.66M | 40.26% | ↗ |
| 65 | 2018 | Michael J. Coyle Executive Vice President and Group President, Cardiac and Vascular Group | 896.9K | — | 1.37M | 910.2K | 2.36M | 121.1K | 5.66M | 40.26% | ↗ |
| 66 | 2018 | Bradley E. Lerman Senior Vice President, General Counsel and Corporate Secretary | 815.4K | — | 1.00M | 670.4K | 1.82M | 107.6K | 4.41M | 37.89% | ↗ |
| 67 | 2018 | Karen L. Parkhill Executive Vice President & Chief Financial Officer | 807.7K | — | 1.13M | 757.6K | 828.8K | 101.1K | 3.63M | 52.11% | ↗ |
| 68 | 2018 | Karen L. Parkhill Executive Vice President and Chief Financial Officer | 807.7K | — | 1.13M | 757.6K | 828.8K | 101.1K | 3.63M | 52.11% | ↗ |
| 69 | 2017 | Omar Ishrak Chairman and Chief Executive Officer | 1.59M | — | 4.50M | 3.04M | 6.14M | 419.4K | 15.69M | 48.05% | ↗ |
| 70 | 2017 | Karen L. Parkhill Executive Vice President and Chief Financial Officer | 620.2K | 1.00M | 5.40M | 691.9K | 778.9K | 934.6K | 9.43M | 64.63% | ↗ |
| 71 | 2017 | Karen L. Parkhill Executive Vice President & Chief Financial Officer | 620.2K | 1.00M | 5.40M | 691.9K | 778.9K | 934.6K | 9.43M | 64.63% | ↗ |
| 72 | 2017 | Michael J. Coyle Executive Vice President & Group President Cardiac and Vascular Group | 876.9K | — | 5.37M | 939.4K | 1.72M | 123.7K | 9.03M | 69.84% | ↗ |
| 73 | 2017 | Michael J. Coyle Executive Vice President and Group President, Cardiac and Vascular Group | 876.9K | — | 5.37M | 939.4K | 1.72M | 123.7K | 9.03M | 69.84% | ↗ |
| 74 | 2017 | Bryan C. Hanson Executive Vice President & Group President, Minimally Invasive Therapies Group | 837.1K | — | 5.22M | 838.1K | 793.0K | 86.1K | 7.77M | 77.91% | ↗ |
| 75 | 2017 | Gary L. Ellis Former Executive Vice President and Chief Financial Officer | 649.5K | — | 1.46M | 1.00M | 1.73M | 554.9K | 5.39M | 45.60% | ↗ |
| 76 | 2017 | Rob ten Hoedt Executive Vice President & President Europe, Middle East and Africa Region | 781.4K | — | 1.77M | 534.4K | 1.04M | 1.26M | 5.38M | 42.74% | ↗ |
| 77 | 2017 | Bradley E. Lerman Senior Vice President, General Counsel and Corporate Secretary | 798.1K | 250.0K | 1.00M | 691.9K | 1.27M | 208.5K | 4.22M | 40.14% | ↗ |
| 78 | 2016 | Omar Ishrak Chairman and Chief Executive Officer | 1.55M | — | 4.33M | 3.02M | 6.07M | 302.5K | 15.27M | 48.13% | ↗ |
| 79 | 2016 | Gary L. Ellis Former Executive Vice President and Chief Financial Officer | 874.1K | — | 1.46M | 1.03M | 2.00M | 702.6K | 6.06M | 41.08% | ↗ |
| 80 | 2016 | Gary L. Ellis Executive Vice President and Chief Financial Officer | 874.1K | — | 1.46M | 1.03M | 2.00M | 702.6K | 6.06M | 41.08% | ↗ |
| 81 | 2016 | Michael J. Coyle Executive Vice President and Vascular Group | 799.0K | — | 1.22M | 864.7K | 1.65M | 110.2K | 4.64M | 44.82% | ↗ |
| 82 | 2016 | Michael J. Coyle Executive Vice President & Group President Cardiac and Vascular Group | 799.0K | — | 1.22M | 864.7K | 1.65M | 110.2K | 4.64M | 44.82% | ↗ |
| 83 | 2016 | Bradley E. Lerman Senior Vice President, General Counsel and Corporate Secretary | 749.0K | 250.0K | 933.3K | 667.4K | 706.6K | 261.5K | 3.57M | 44.87% | ↗ |
| 84 | 2016 | Bradley E. Lerman Senior Vice President, General Counsel, Corporate Secretary | 749.0K | 250.0K | 933.3K | 667.4K | 706.6K | 261.5K | 3.57M | 44.87% | ↗ |
| 85 | 2016 | Bryan C. Hanson Executive Vice President & Group President, Minimally Invasive Therapies Group | 775.8K | 25.0K | 966.7K | 690.6K | 847.9K | 116.0K | 3.42M | 48.43% | ↗ |
| 86 | 2016 | Bryan C. Hanson Executive Vice President Invasive Therapies Group | 775.8K | 25.0K | 966.7K | 690.6K | 847.9K | 116.0K | 3.42M | 48.43% | ↗ |
| 87 | 2015 | Omar Ishrak Chairman and Chief Executive Officer | 1.50M | — | 3.50M | 3.08M | 5.61M | 24.85M | 38.54M | 17.07% | ↗ |
| 88 | 2015 | Gary L. Ellis Executive Vice President and Chief Financial Officer | 829.0K | — | 1.12M | 1.00M | 1.78M | 9.80M | 14.53M | 14.60% | ↗ |
| 89 | 2015 | Gary L. Ellis Former Executive Vice President and Chief Financial Officer | 829.0K | — | 1.12M | 1.00M | 1.78M | 9.80M | 14.53M | 14.60% | ↗ |
| 90 | 2015 | Gary L. Ellis Senior Vice President and Chief Financial Officer | 829.0K | — | 1.12M | 1.00M | 1.78M | 9.32M | 14.05M | 15.09% | ↗ |
| 91 | 2015 | Bryan C. Hanson Executive Vice President Invasive Therapies Group | 400.8K | 1.00M | 3.80M | 1.41M | 480.7K | 4.84M | 11.94M | 43.66% | ↗ |
| 92 | 2015 | Christopher J. O’Connell Executive Vice President Therapies Group | 695.6K | — | 892.0K | 806.6K | 1.47M | 7.89M | 11.76M | 14.45% | ↗ |
| 93 | 2015 | Michael J. Coyle Executive Vice President Vascular Group | 747.6K | — | 892.0K | 806.6K | 1.52M | 5.87M | 9.83M | 17.27% | ↗ |
| 94 | 2015 | Michael J. Coyle Executive Vice President and Vascular Group | 747.6K | — | 892.0K | 806.6K | 1.52M | 5.65M | 9.61M | 17.67% | ↗ |
| 95 | 2015 | Michael J. Coyle Executive Vice President & Group President Cardiac and Vascular Group | 747.6K | — | 892.0K | 806.6K | 1.52M | 5.65M | 9.61M | 17.67% | ↗ |
| 96 | 2014 | Omar Ishrak Chairman and Chief Executive Officer | 1.46M | — | 3.07M | 2.66M | 4.68M | 250.8K | 12.12M | 47.25% | ↗ |
| 97 | 2014 | Gary L. Ellis Executive Vice President and Chief Financial Officer | 774.9K | — | 833.0K | 744.1K | 1.45M | 572.5K | 4.38M | 36.04% | ↗ |
| 98 | 2014 | Gary L. Ellis Senior Vice President and Chief Financial Officer | 774.9K | — | 833.0K | 744.1K | 1.45M | 572.5K | 4.38M | 36.04% | ↗ |
| 99 | 2014 | Bryan C. Hanson Executive Vice President & Group President, Minimally Invasive Therapies Group | 595.3K | — | 1.61M | 963.7K | 736.5K | 81.2K | 3.99M | 64.56% | ↗ |
| 100 | 2014 | Bryan C. Hanson Executive Vice President Invasive Therapies Group | 595.3K | — | 1.61M | 963.7K | 736.5K | 81.2K | 3.99M | 64.56% | ↗ |
| 101 | 2014 | Christopher J. O’Connell Executive Vice President Therapies Group | 675.1K | — | 833.0K | 744.1K | 1.26M | 270.8K | 3.79M | 41.66% | ↗ |
| 102 | 2014 | Michael J. Coyle Executive Vice President Vascular Group | 724.9K | — | 767.0K | 686.4K | 1.31M | 106.3K | 3.59M | 40.47% | ↗ |
| 103 | 2014 | Michael J. Coyle Executive Vice President and Vascular Group | 724.9K | — | 767.0K | 686.4K | 1.31M | 106.3K | 3.59M | 40.47% | ↗ |
| 104 | 2013 | Omar Ishrak Chairman and Chief Executive Officer | 1.40M | — | 2.82M | 2.10M | 2.42M | 239.7K | 8.98M | 54.77% | ↗ |
| 105 | 2013 | Gary L. Ellis Senior Vice President and Chief Financial Officer | 716.5K | — | 800.0K | 615.5K | 1.30M | 438.5K | 3.87M | 36.55% | ↗ |
| 106 | 2013 | Christopher J. O’Connell Executive Vice President Therapies Group | 630.2K | — | 734.0K | 565.6K | 1.17M | 290.0K | 3.39M | 38.35% | ↗ |
| 107 | 2013 | Michael J. Coyle Executive Vice President Vascular Group | 670.2K | — | 734.0K | 565.6K | 1.21M | 84.5K | 3.26M | 39.81% | ↗ |
| 108 | 2013 | Bryan C. Hanson Executive Vice President Invasive Therapies Group | 556.6K | — | 1.30M | 719.5K | 585.2K | 54.1K | 3.22M | 62.82% | ↗ |
| 109 | 2012 | Bryan C. Hanson Executive Vice President Invasive Therapies Group | 535.2K | — | 1.22M | 725.5K | 356.0K | 530.0K | 3.37M | 57.83% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Geoffrey Straub Martha | Chairman of the Board & Chief Executive Officer | 4M | male |
| Brett A. Wall | Executive Vice President & President of Neuroscience Portfolio | 2M | male |
| Michelle Quinn | Executive Vice President, General Counsel & Secretary | 985.6K | female |
| Thierry Pieton | Executive Vice President & Chief Financial Officer | 421.8K | male |
| Alex Gu | Senior VP & President of Greater China Region | — | male |
| Mark Ploof | Senior Vice President of Global Operations and Business Services | — | male |
| Matthew Walter | Senior Vice President of Human Resources, IT and Global Communications & Corporate Marketing | — | male |
| Rogerio Branco | SVP & Chief Operations and Supply Chain Officer | — | male |
| Laura Mauri | Senior Vice President and Chief Scientific & Medical Officer | — | — |
| Denise L. Blomquist | Vice President, Global Controller & Chief Accounting Officer | — | female |
| Ingrid Goldberg | Vice President & Head of Investor Relations | — | female |
| Jason Weidman | Senior VP and President of Coronary & Renal Denervation business | — | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
| Transaction Date | Disclosed | Senator | State | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2024-08-26 | 2024-09-13 | Tommy Tuberville | AL | Joint | Sale (Full) | $15,001 - $50,000 | ↗ |
| 2024-02-09 | 2024-03-15 | Shelley Moore Capito | WV | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2023-09-21 | 2023-10-20 | Pete Ricketts | NE | Spouse | Sale (Full) | $50,001 - $100,000 | ↗ |
| 2023-04-05 | 2023-04-19 | Tina Smith | MN | Spouse | Sale (Full) | $100,001 - $250,000 | ↗ |
| 2022-11-30 | 2023-07-26 | Dan Sullivan | AK | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2022-01-21 | 2022-02-14 | Tommy Tuberville | AL | Joint | Sale (Full) | $15,001 - $50,000 | ↗ |
| 2020-11-05 | 2020-12-08 | Bill Cassidy | LA | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-03-09 | 2020-03-27 | Bill Cassidy | LA | Spouse | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2019-01-25 | 2019-02-21 | Bill Cassidy | LA | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2018-12-07 | 2019-08-07 | Bill Cassidy | LA | Spouse | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2018-04-24 | 2019-05-09 | Shelley Moore Capito | WV | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2018-04-23 | 2018-05-15 | Bill Cassidy | LA | Spouse | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2018-04-05 | 2018-05-14 | Shelley Moore Capito | WV | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2017-10-24 | 2018-10-26 | Bill Cassidy | LA | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2017-06-15 | 2017-06-22 | Patty Murray | WA | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2017-03-16 | 2017-03-21 | Patty Murray | WA | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2017-01-11 | 2017-02-14 | Sheldon Whitehouse | RI | Child | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2016-09-26 | 2016-10-04 | Thomas R. Carper | DE | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2016-04-19 | 2016-05-04 | Shelley Moore Capito | WV | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2015-01-27 | 2016-09-08 | Sheldon Whitehouse | RI | Child | Exchange | $1,001 - $15,000 | ↗ |
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2026-03-20 | 2026-04-06 | Kevin Hern | OK01 | Joint | Sale | $15,001 - $50,000 | ↗ |
| 2025-12-18 | 2026-01-16 | Julie Johnson | TX32 | Joint | Sale | $1,001 - $15,000 | ↗ |
| 2025-11-13 | 2025-12-12 | Julie Johnson | TX32 | Joint | Sale | $1,001 - $15,000 | ↗ |
| 2025-11-05 | 2025-12-10 | Rich McCormick | — | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-08-14 | 2025-09-12 | Julie Johnson | TX32 | Joint | Sale | $1,001 - $15,000 | ↗ |
| 2025-06-27 | 2025-07-10 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-05-15 | 2025-06-02 | Rob Bresnahan | PA08 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-04-08 | 2025-04-29 | Rob Bresnahan | PA08 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-03-24 | 2025-04-23 | George Whitesides | CA27 | — | Sale (Full) | $50,001 - $100,000 | ↗ |
| 2025-03-20 | 2025-04-17 | Bruce Westerman | AR04 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-03-04 | 2025-04-17 | Bruce Westerman | AR04 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-02-25 | 2025-03-28 | Rob Bresnahan | PA08 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2025-01-06 | 2025-02-11 | Emily Randall | WA06 | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2024-11-15 | 2024-12-06 | Ro Khanna | CA17 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2024-09-04 | 2024-09-06 | John James | MI10 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2024-07-09 | 2024-08-06 | Earl Blumenauer | OR03 | Spouse | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2024-07-02 | 2024-08-16 | Kathy Manning | NC06 | Spouse | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2024-06-18 | 2024-09-02 | John James | MI10 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2024-06-03 | 2024-09-02 | John James | MI10 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2024-02-13 | 2024-03-06 | Ro Khanna | CA17 | — | Sale | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MDT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
